<SEC-DOCUMENT>0001193125-25-335370.txt : 20251229
<SEC-HEADER>0001193125-25-335370.hdr.sgml : 20251229
<ACCEPTANCE-DATETIME>20251229161746
ACCESSION NUMBER:		0001193125-25-335370
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20251229
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251229
DATE AS OF CHANGE:		20251229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hyperfine, Inc.
		CENTRAL INDEX KEY:			0001833769
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39949
		FILM NUMBER:		251609404

	BUSINESS ADDRESS:	
		STREET 1:		351 NEW WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437
		BUSINESS PHONE:		866-796-6767

	MAIL ADDRESS:	
		STREET 1:		351 NEW WHITFIELD STREET
		CITY:			GUILFORD
		STATE:			CT
		ZIP:			06437

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HealthCor Catalio Acquisition Corp.
		DATE OF NAME CHANGE:	20201124
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d76508d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hypr="http://hyperfine.io/20251229" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-285">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-12-29_to_2025-12-29">0001833769</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="hypr-20251229.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-12-29_to_2025-12-29"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001833769</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-12-29</xbrli:startDate> <xbrli:endDate>2025-12-29</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-296">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt:datemonthdayyearen" id="ixv-297">December 29, 2025</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-298">Hyperfine, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:stateprovnameen" id="ixv-299">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-300">001-39949</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-301">98-1569027</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-302">351 New Whitfield Street</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-303">Guilford</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:stateprovnameen" id="ixv-304">Connecticut</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-305">06437</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-306">(866)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-307">796-6767</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:boolballotbox" id="ixv-308">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:boolballotbox" id="ixv-309">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:boolballotbox" id="ixv-310">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:boolballotbox" id="ixv-311">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-312">Class&#160;A common stock, $0.0001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-313">HYPR</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:exchnameen" id="ixv-314">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#160;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:boolballotbox" id="ixv-315">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. <ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2025-12-29_to_2025-12-29" format="ixt-sec:boolballotbox" id="ixv-316">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;1.01 Entry into a Material Definitive Agreement. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 29, 2025, Hyperfine,&#160;Inc. (the &#8220;Company&#8221;) entered into an Amended and Restated At Market Issuance Sales Agreement (the &#8220;Amended and Restated Sales Agreement&#8221;) with B. Riley Securities, Inc. (&#8220;B. Riley&#8221;) and BTIG, LLC (&#8220;BTIG&#8221;) with respect to an <span style="white-space:nowrap"><span style="white-space:nowrap">at-the-market</span></span> offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its Class&#160;A common stock, par value $0.0001 per share (the &#8220;Class&#160;A common stock&#8221;), having an aggregate offering price of up to $50.0&#160;million (the &#8220;Placement Shares&#8221;) through or to B. Riley and BTIG as sales agents or principals. The Amended and Restated Sales Agreement amends and restates the At Market Issuance Sales Agreement with B. Riley, previously entered into on November&#160;9, 2023 (the &#8220;Original Sales Agreement&#8221;), to add BTIG as an additional sales agent (B. Riley and BTIG, together, the &#8220;Sales Agents&#8221;). No other material<span style="font-weight:bold"> </span>terms of the <span style="white-space:nowrap"><span style="white-space:nowrap">at-the-market</span></span> offering program or Original Sales Agreement were amended. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon delivery of a placement notice and subject to the terms and conditions of the Amended and Restated Sales Agreement, the Sales Agents may sell the Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act of 1933, as amended. The Sales Agents will use commercially reasonable efforts to sell the Placement Shares from time to time, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay the Sales Agents a commission equal to up to three percent (3.0%) of the gross sales proceeds of any Placement Shares sold through the Sales Agents under the Amended and Restated Sales Agreement, and also has provided the Sales Agents with customary indemnification and contribution rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is not obligated to make any sales of Class&#160;A common stock under the Amended and Restated Sales Agreement. The offering of Placement Shares pursuant to the Amended and Restated Sales Agreement will terminate upon the earlier of (i)&#160;the sale of all Placement Shares subject to the Amended and Restated Sales Agreement or (ii)&#160;termination of the Amended and Restated Sales Agreement in accordance with its terms. The foregoing description of the material terms of the Amended and Restated Sales Agreement is qualified in its entirety by reference to the full agreement, a copy of which is attached as Exhibit 10.1 hereto and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. relating to the validity of the Placement Shares is attached as Exhibit 5.1 hereto and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;8.01 Other Events. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 29, 2025, the Company filed a prospectus supplement (the &#8220;Prospectus Supplement&#8221;) in connection with the Amended and Restated Sales Agreement. The Placement Shares will be offered and sold by the Sales Agents pursuant to the Company&#8217;s effective shelf registration statement on Form <span style="white-space:nowrap">S-3</span> (Registration <span style="white-space:nowrap">No.&#160;333-275449),</span> the underlying base prospectus and the Prospectus Supplement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering of the Company&#8217;s Class&#160;A common stock pursuant to the prospectus supplement dated November&#160;22, 2023 is hereby terminated such that no further offers or sales will be made pursuant to such prospectus supplement. As of the date of this report, 3,464,325 shares of Class&#160;A common stock have been sold under such prospectus supplement, for aggregate gross proceeds of approximately $4.35&#160;million, before deducting sales agent&#8217;s commissions. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01 Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d76508dex51.htm">Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d76508dex101.htm">Amended and Restated Sales Agreement, dated as of December 29, 2025, by and between Hyperfine, Inc. and B. Riley Securities, Inc. and BTIG, LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d76508dex51.htm">Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in Exhibit&#160;5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">HYPERFINE, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: December 29, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brett Hale</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Brett Hale</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Administrative Officer, Chief Financial Officer,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Treasurer and Corporate Secretary</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d76508dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g76508g1223171912109.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">One Financial Center</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Boston, MA 02111</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">617 542 6000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">mintz.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">December 29, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hyperfine, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">351 New Whitfield Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guilford, CT 06437 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as legal counsel to Hyperfine, Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the preparation and
filing with the Securities and Exchange Commission (the &#8220;Commission&#8221;) of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (the &#8220;Registration Statement&#8221;), pursuant to which the Company registered
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), up to $150,000,00 of any combination of securities described therein. The Registration Statement was declared effective by the Commission on November&nbsp;22,
2023.&nbsp;We have also acted as legal counsel for the Company in connection with the sales agreement prospectus supplement, dated December 29, 2025 (the &#8220;Prospectus Supplement&#8221;), to the base prospectus included in the Registration
Statement relating to the issuance and sale of shares of the Company&#8217;s Class&nbsp;A common stock, $0.0001 par value per share (the &#8220;Common Stock&#8221;) having an aggregate offering price of up to $50,000,000 (the &#8220;Shares&#8221;)
under an Amended and Restated At Market Issuance Sales Agreement, dated December 29, 2025 (the &#8220;Sales Agreement&#8221;), between the Company and B. Riley Securities, Inc. and BTIG, LLC, which Prospectus Supplement replaces, updates, amends and
supplements the prospectus supplement to the Registration Statement, dated November&nbsp;22, 2023. The Sales Agreement will be filed as an exhibit to a Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;and</FONT> incorporated by
reference into the Registration Statement.&nbsp;This opinion is being rendered in connection with the filing of the Prospectus Supplement with the Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined the Company&#8217;s Certificate of Incorporation, as amended (the &#8220;Certificate of
Incorporation&#8221;), and Amended and Restated Bylaws (the &#8220;Bylaws&#8221;), each as currently in effect; such other records of the corporate proceedings of the Company and certificates of the Company&#8217;s officers as we have deemed
relevant; the Registration Statement and the exhibits thereto; and the Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our examination, we have assumed the
genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies and the authenticity of the
originals of such copies. We have relied as to certain matters on information obtained from public officials, officers of the Company, and other sources believed by us to be responsible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinion is limited to the General Corporation Law of the State of Delaware and the laws of the State of New York. Without limiting the
generality of the foregoing, we express no opinion with respect to (i)&nbsp;the qualification of the Shares under the securities or blue sky laws of any state or any foreign jurisdiction or (ii)&nbsp;the compliance with any federal or state law,
rule or regulation relating to securities, or to the sale or issuance thereof. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BOSTON&#8195;&#8195;LOS ANGELES&#8195;&#8195;NEW YORK&#8195;&#8195;SAN DIEGO&#8195;&#8195;SAN FRANCISCO&#8195;&#8195;TORONTO&#8195;&#8195;
WASHINGTON </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MINTZ</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December 29, 2025</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Page 2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g76508g1223171912214.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, we are of the opinion that the Shares have been duly authorized
for issuance and, when the Shares have been issued and paid for in accordance with the terms and conditions of the Sales Agreement, the Shares will be validly issued, fully paid and non-assessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters.
This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might
affect any matters or opinions set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We understand that you wish to file this opinion with the Commission as an exhibit to a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> for incorporation by reference into the Registration Statement&nbsp;in accordance with the requirements of Item 601(b)(5)&nbsp;of
<FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> promulgated under the Securities Act and to reference the firm&#8217;s name under the caption &#8220;Legal Matters&#8221; in the Prospectus Supplement, and we hereby consent thereto. In
giving this consent, we do not admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d76508dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HYPERFINE, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Class&nbsp;A Common Stock </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(par
value $0.0001 per share) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amended And Restated At Market Issuance Sales Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">December 29, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B. Riley Securities, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">299 Park Avenue, 21<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10171 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BTIG, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Hyperfine, Inc., a Delaware corporation (the &#8220;<U>Company</U>&#8221;), and B. Riley Securities, Inc. (&#8220;<U>B. Riley
Securities</U>&#8221;) are parties to that certain At Market Issuance Sales Agreement, dated November&nbsp;9, 2023 (the &#8220;<U>Original Agreement</U>&#8221;). The Company, B. Riley Securities, and BTIG, LLC (&#8220;<U>BTIG</U>&#8221;; each of B.
Riley Securities and BTIG individually an &#8220;<U>Agent</U>&#8221; and together, the &#8220;<U>Agents</U>&#8221;) desire to amend and restate the Original Agreement in its entirety as set forth in this Agreement (the
&#8220;<U>Agreement</U>&#8221;) and hereby agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Issuance and Sale of Shares</U>. The Company agrees that, from time to
time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through or to the Agents, as sales agents or principals, shares (the &#8220;<U>Placement Shares</U>&#8221;)<I> </I>of the
Company&#8217;s Class&nbsp;A common stock, par value $0.0001 per share (the &#8220;<U>Common Stock</U>&#8221;); <I>provided however, </I>that in no event shall the Company issue or sell through the Agents such number of Placement Shares that
(a)&nbsp;exceeds the number of shares or dollar amount of Common Stock registered on the effective Registration Statement (as defined below) pursuant to which the offering is being made or (b)&nbsp;exceeds the number of shares or dollar amount
registered on the Prospectus Supplement (as defined below) (the lesser of (a)&nbsp;or (b), the &#8220;<U>Maximum Amount</U>&#8221;) and <I>provided further, however,</I> that in no event shall the aggregate number of Placement Shares sold pursuant
to this Agreement exceed the number of authorized but unissued shares of Common Stock. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in this
<U>Section</U><U></U><U>&nbsp;1</U> on the number of Placement Shares issued and sold under this Agreement shall be the sole responsibility of the Company and that the Agents shall have no obligation in connection with such compliance. The issuance
and sale of Placement Shares through the Agents will be effected pursuant to the Registration Statement (as defined below), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement to issue any
Placement Shares. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has filed, in accordance with the provisions of the Securities Act of 1933, as
amended, and the rules and regulations thereunder (the &#8220;<U>Securities Act</U>&#8221;), with the Securities and Exchange Commission (the &#8220;<U>Commission</U>&#8221;), a registration statement on Form
<FONT STYLE="white-space:nowrap">S-3,</FONT> including a base prospectus, relating to certain securities, including the Placement Shares to be issued from time to time by the Company, and which incorporates by reference documents that the Company
has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the &#8220;<U>Exchange Act</U>&#8221;). The Company has prepared a prospectus supplement to the
base prospectus included as part of the registration statement specifically relating to the Placement Shares (the &#8220;<U>Prospectus Supplement</U>&#8221;). The Company will furnish to the Agents, for use by the Agents, copies of the base
prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement relating to the Placement Shares. Except where the context otherwise requires, such registration statement, and any post-effective amendment
thereto, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the
Securities Act or deemed to be a part of such registration statement pursuant to Rule&nbsp;430B of the Securities Act, or any subsequent registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> filed pursuant to Rule 415 under the
Securities Act by the Company to cover any Placement Shares, is herein called the &#8220;<U>Registration Statement</U>.&#8221; The base prospectus, including all documents incorporated or deemed incorporated therein by reference to the extent such
information has not been superseded or modified in accordance with Rule 412 under the Securities Act (as qualified by Rule 430B(g) of the Securities Act), included in the Registration Statement, as it may be supplemented by the Prospectus
Supplement, in the form in which such base prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any then issued Issuer Free Writing
Prospectus (as defined below), is herein called the &#8220;<U>Prospectus</U>.&#8221; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents
incorporated by reference therein, and any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include
the filing after the execution hereof of any document with the Commission incorporated by reference therein (the &#8220;<U>Incorporated Documents</U>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall
be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System, or if applicable, the Interactive Data Electronic Application system when used by the Commission
(collectively, &#8220;<U>EDGAR</U>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Placements</U>. Each time that the Company wishes to issue and sell Placement Shares
hereunder (each, a &#8220;<U>Placement</U>&#8221;), it will notify an Agent (the &#8220;<U>Designated Agent</U>&#8221;) by electronic mail (or other method mutually agreed to in writing by the parties) of the number of Placement Shares, the time
period during which sales are requested to be made, any limitation on the number of Placement Shares that may be sold in any one day and any minimum price below which sales may not be made (a &#8220;<U>Placement Notice</U>&#8221;), the form of which
is attached hereto as <U>Schedule 1</U>. The Placement Notice shall originate from any of the individuals from the Company set forth on <U>Schedule 3</U> (with a copy to each of the other individuals from the Company listed on such schedule), and
shall be addressed to each of the individuals from the Designated Agent set forth on <U>Schedule 3</U>, as such <U>Schedule 3</U> may be amended from time to time. The Placement Notice shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be effective immediately upon receipt by the Designated Agent unless and until (i)&nbsp;the Designated Agent declines in writing to accept the terms contained therein for any reason, in its sole
discretion, (ii)&nbsp;the entire amount of the Placement Shares thereunder has been sold, (iii)&nbsp;the Company suspends or terminates the Placement Notice, which suspension and termination rights may be exercised by the Company in its sole
discretion, or (iv)&nbsp;this Agreement has been terminated under the provisions of <U>Section</U><U></U><U>&nbsp;13</U>. The amount of any discount, commission or other compensation to be paid by the Company to the Designated Agent in connection
with the Designated Agent&#8217;s sale of the Placement Shares shall be calculated in accordance with the terms set forth in <U>Schedule 2</U>. It is expressly acknowledged and agreed that neither the Company nor the Designated Agent will have any
obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to the Designated Agent and the Designated Agent does not decline (and the Company does not suspend or terminate) such
Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of <U>Sections 2</U> or <U>3</U> of this Agreement and the terms of a Placement Notice,
the terms of the Placement Notice will control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Sale of Placement Shares by the Agents</U>. Subject to the terms and conditions of
this Agreement, for the period specified in a Placement Notice, the Designated Agent will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and
the rules of the Nasdaq Global Market (the &#8220;<U>Exchange</U>&#8221;), to sell the Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Designated Agent will provide written
confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day,
the compensation payable by the Company to the Designated Agent pursuant to <U>Section</U><U></U><U>&nbsp;2</U> with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by
the Designated Agent (as set forth in <U>Section</U><U></U><U>&nbsp;5(b))</U> from the gross proceeds that it receives from such sales. Subject to the terms of a Placement Notice, the Designated Agent may sell Placement Shares by any method
permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act. &#8220;<U>Trading Day</U>&#8221; means any day on which shares of Common Stock are purchased and sold on the Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Suspension of Sales</U>. The Company or the Designated Agent may, upon notice to the other party in writing (including by email
correspondence to each of the individuals of the other party set forth on <U>Schedule 3</U>, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone
(confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on <U>Schedule </U>3), suspend any sale of Placement Shares (a &#8220;<U>Suspension</U>&#8221;); <I>provided,
however</I>, that such suspension shall not affect or impair any party&#8217;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. While a Suspension is in effect, any obligation under <U>Sections
7(l)</U>, <U>7(m)</U>, and <U>7(n)</U> with respect to the delivery of certificates, opinions, or comfort letters to the Agents, shall be waived. Each of the parties agrees that no such notice under this <U>Section</U><U></U><U>&nbsp;4</U> shall be
effective against any other party unless it is made to one of the individuals named on <U>Schedule 3</U> hereto, as such Schedule may be amended from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Sale and Delivery to the Designated Agent; Settlement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Sale of Placement Shares</U>. On the basis of the representations and warranties herein contained and subject to the terms and
conditions herein set forth, upon the Designated Agent&#8217;s acceptance of the terms of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the
terms of this Agreement, the Designated Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and
regulations and the rules of the Exchange to sell such Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Company acknowledges and agrees that (i)&nbsp;there can be no assurance
that the Designated Agent will be successful in selling Placement Shares, (ii)&nbsp;the Designated Agent will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other
than a failure by the Designated Agent to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Exchange to sell such
Placement Shares as required under this Agreement and (iii)&nbsp;the Designated Agent shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed by the Designated Agent and
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Settlement of Placement Shares</U>. Unless otherwise specified in the applicable Placement Notice, settlement for
sales of Placement Shares will occur on the first&nbsp;(1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) Trading Day (or such earlier day as is industry practice for <FONT STYLE="white-space:nowrap">regular-way</FONT> trading) following the
date on which such sales are made (each, a &#8220;<U>Settlement Date</U>&#8221;). The Designated Agent shall notify the Company of each sale of Placement Shares no later than opening of the Trading Day following the Trading Day that the Designated
Agent sold Placement Shares. The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &#8220;<U>Net Proceeds</U>&#8221;) will be equal to the aggregate sales price received by the
Designated Agent, after deduction for (i)&nbsp;the Designated Agent&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to Section&nbsp;2 hereof, and (ii)&nbsp;any transaction fees imposed by any
governmental or self-regulatory organization in respect of such sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Delivery of Placement Shares</U>. On or before each
Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting the Designated Agent&#8217;s or its designee&#8217;s account (provided the Designated Agent shall have given
the Company written notice of such designee and such designee&#8217;s account information at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other
means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, the Designated Agent will deliver the related Net
Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver Placement Shares on a
Settlement Date through no fault of the Designated Agent and provided that the Designated Agent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has not declined the applicable Placement Notice, then in addition to and in no way limiting the rights and obligations set forth in <U>Section</U><U></U><U>&nbsp;11(a)</U> hereto, it will
(i)&nbsp;hold the Designated Agent harmless against any loss, claim, damage, or reasonable, documented expense (including reasonable and documented legal fees and expenses), as incurred, arising out of or in connection with such default by the
Company or its transfer agent (if applicable) and (ii)&nbsp;pay to the Designated Agent (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Limitations on Offering Size</U>. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares
if, after giving effect to the sale of such Placement Shares, the aggregate number of Placement Shares sold pursuant to this Agreement would exceed the lesser of (A)&nbsp;together with all sales of Placement Shares under this Agreement, the Maximum
Amount, (B)&nbsp;the amount available for offer and sale under the currently effective Registration Statement and (C)&nbsp;the amount authorized from time to time to be issued and sold under this Agreement by the Company&#8217;s board of directors,
a duly authorized committee thereof or a duly authorized executive committee, and notified to the Designated Agent in writing. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this
Agreement at a price lower than the minimum price authorized from time to time by the Company&#8217;s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to the Designated Agent in writing.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Sales Through Agents</U>. The Company agrees that any offer to sell, any solicitation of an offer to buy, or any sales of Placement
Shares or any other equity security of the Company shall only be effected by or through an Agent, and only a single Agent, on any single given date, and in no event shall the Company request that more than one Agent sell Placement Shares on the same
day; provided however that (i)&nbsp;the foregoing limitation shall not apply to (A)&nbsp;exercise of any option, warrant, right or any conversion privilege set forth in the instruction governing such securities, (B)&nbsp;sales solely to employees,
directors or security holders of the Company or its subsidiaries, or to a trustee or other person acquiring such securities for the accounts of such person and (ii)&nbsp;such limitation shall not apply (A)&nbsp;on any day during which no sales are
made pursuant to this Agreement or (B)&nbsp;during a period in which the Company has notified the Agents that it will not sell Common Stock under this Agreement and (1)&nbsp;no Placement Notice is pending or (2)&nbsp;after a Placement Notice has
been withdrawn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Representations and Warranties of the Company</U>. Except as disclosed in the Registration Statement or Prospectus
(including the Incorporated Documents), the Company represents and warrants to, and agrees with each of the Agents that as of the date of this Agreement and as of each Applicable Time (as defined below), unless such representation, warranty or
agreement specifies a different date or time: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Registration Statement and Prospectus</U>. The transactions contemplated by this
Agreement meet the requirements for and comply with the conditions for the use of <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> under the Securities Act. The Registration Statement has been or will be filed with the Commission and has been
or will be declared effective under the Securities Act. The Prospectus Supplement will name B. Riley Securities and BTIG as the agents in the section entitled &#8220;Plan of Distribution.&#8221; The Company has not received, and has no notice of,
any order of the Commission preventing or suspending the use of the Registration Statement, or threatening or instituting proceedings for that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purpose. The Registration Statement and the offer and sale of Placement Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material
respects with said Rule. Any statutes, regulations, contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement have been so described or
filed, as applicable. Copies of the Registration Statement, the Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have
been delivered, or are available through EDGAR, to the Agents and their counsel. The Company has not distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Placement Shares, will not distribute
any offering material in connection with the offering or sale of the Placement Shares other than the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus (as defined below) to which the Agents have consented, which
consent will not be unreasonably withheld, conditioned or delayed, or that is required by applicable law or the listing maintenance requirements of the Exchange. The Common Stock is currently quoted on the Exchange under the trading symbol
&#8220;HYPR.&#8221; The Company has not, in the 12&nbsp;months preceding the date hereof, received notice from the Exchange to the effect that the Company is not in compliance with the listing or maintenance requirements of the Exchange. To the
Company&#8217;s knowledge, it is in compliance with all such listing and maintenance requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>No Misstatement or Omission</U>.
At each Settlement Date, the Registration Statement and the Prospectus, as of such date, will conform in all material respects with the requirements of the Securities Act. The Registration Statement, when it became or becomes effective, did not, and
will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendment and supplement thereto, on the date
thereof and at each Applicable Time (defined below), did not or will not include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading. The documents incorporated by reference in the Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue
statement of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they were made, not misleading. The foregoing shall
not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by an Agent specifically for use in the preparation thereof, it being understood and agreed that the
only such information furnished by the Agents to the Company consists of &#8220;Agents Information&#8221; as defined below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c.
<U>Conformity with Securities Act and Exchange Act</U>. The Registration Statement, the Prospectus, any Issuer Free Writing Prospectus or any amendment or supplement thereto, and the Incorporated Documents, when such documents were or are filed with
the Commission under the Securities Act or the Exchange Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and the Exchange
Act, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Financial Information</U>. The consolidated financial statements of the Company
included or incorporated by reference in the Registration Statement and the Prospectus, together with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and the Subsidiaries
(as defined below) as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders&#8217; equity of the Company and the Subsidiaries for the periods specified (subject, in the case of unaudited
statements, to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments which will not be material, either individually or in the aggregate) and have been prepared in compliance with the published requirements of the Securities Act
and Exchange Act, as applicable, and in conformity with generally accepted accounting principles in the United States (&#8220;<U>GAAP</U>&#8221;) applied on a consistent basis (except (i)&nbsp;for such adjustments to accounting standards and
practices as are noted therein and (ii)&nbsp;in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) during the periods involved; the other financial and statistical data with
respect to the Company and the Subsidiaries contained or incorporated by reference in the Registration Statement and the Prospectus, are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and
records of the Company; there are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Registration Statement or the Prospectus that are not included or incorporated by reference as
required; the Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off balance sheet obligations), not described in the Registration Statement and the Prospectus which are required to
be described in the Registration Statement or Prospectus; and all disclosures contained or incorporated by reference in the Registration Statement and the Prospectus, if any, regarding &#8220;non-GAAP financial measures&#8221; (as such term is
defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act, to the extent applicable.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Conformity with EDGAR Filing</U>. The Prospectus delivered to the Agents for use in connection with the sale of the Placement
Shares pursuant to this Agreement will be identical to the versions of the Prospectus created to be transmitted to the Commission for filing via EDGAR, except to the extent permitted by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <U>Organization</U>. The Company and any subsidiary that is a significant subsidiary (as such term is defined in Rule <FONT
STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the Commission) (each, a &#8220;<U>Subsidiary</U>,&#8221; collectively, the &#8220;<U>Subsidiaries</U>&#8221;), are, and will be, duly
incorporated or organized, as the case may be, validly existing as a corporation or other entity and in good standing under the laws of their respective jurisdictions of incorporation or organization. The Company and the Subsidiaries are duly
licensed or qualified as a foreign corporation or other entity for the transaction of business and in good standing under the laws of each other jurisdiction in which their respective ownership or lease of property or the conduct of their respective
businesses requires such license or qualification, and have all corporate power and authority necessary to own or hold their respective properties and to conduct their respective businesses as described in the Registration Statement and the
Prospectus, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the assets, business, operations, earnings, properties,
condition (financial or otherwise), prospects, stockholders&#8217; equity or results of operations of the Company and the Subsidiaries taken as a whole, or prevent the consummation of the transactions contemplated hereby (a &#8220;<U>Material
Adverse Effect</U>&#8221;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. <U>Subsidiaries</U>. The Company owns directly or indirectly, all of the equity interests
of the Subsidiaries free and clear of any lien, charge, security interest, encumbrance, right of first refusal or other restriction, and all the equity interests of the Subsidiaries are validly issued and are fully paid, nonassessable and free of
preemptive and similar rights. The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit 21.1 to the Company&#8217;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the most recently ended fiscal year and other than (i)&nbsp;those subsidiaries not required to be listed on Exhibit 21.1 by Item 601 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the
Exchange Act and (ii)&nbsp;those subsidiaries formed since the last day of the most recently ended fiscal year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. <U>No Violation or
Default</U>. Neither the Company nor any Subsidiary is (i)&nbsp;in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or
lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other similar agreement or instrument to which the
Company or any Subsidiary is a party or by which the Company or any Subsidiary is bound or to which any of the property or assets of the Company or any Subsidiary is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order,
rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of each of clauses (ii)&nbsp;and (iii) above, for any such violation or default that would not, individually or in the aggregate, have a
Material Adverse Effect. To the Company&#8217;s knowledge, no other party under any material contract or other agreement to which it or any Subsidiary is a party is in default in any respect thereunder where such default would have a Material
Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. <U>No Material Adverse Effect</U>. Since the date of the most recent financial statements of the Company included or
incorporated by reference in the Registration Statement and Prospectus, there has not been (i)&nbsp;any Material Adverse Effect, or any development that would result in a Material Adverse Effect, (ii)&nbsp;any transaction which is material to the
Company and the Subsidiaries taken as a whole, (iii)&nbsp;any obligation or liability, direct or contingent (including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), incurred by the Company or the Subsidiaries, which is
material to the Company and the Subsidiaries taken as a whole, (iv)&nbsp;any material change in the capital stock (other than (A)&nbsp;the grant of additional options, restricted stock units or other equity awards under the Company&#8217;s existing
equity incentive plans, (B)&nbsp;changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock outstanding on the date
hereof, (C)&nbsp;as a result of the issuance of Placement Shares, (D)&nbsp;any repurchases of capital stock of the Company, (E)&nbsp;as described in a proxy statement filed on Schedule 14A or a Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-4,</FONT> (F) securities offered and sold pursuant to the Registration Statement or (G)&nbsp;otherwise publicly announced) or outstanding long-term indebtedness of the Company or the Subsidiaries or (v)&nbsp;any dividend
or distribution of any kind declared, paid or made on the capital stock of the Company, other than in each case above in the ordinary course of business or as otherwise disclosed in the Registration Statement or Prospectus (including any document
incorporated by reference therein), or where the failure to disclose such matter, item, change or development would not make the statements in the Registration Statement or Prospectus contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">j. <U>Capitalization</U>. The issued and outstanding shares of capital stock of the Company
have been validly issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and, other than as disclosed in the Registration Statement or the Prospectus, are not subject to any preemptive rights, rights of first refusal or
similar rights. The Company has an authorized, issued and outstanding capitalization as set forth in the Registration Statement and the Prospectus as of the dates referred to therein (other than (i)&nbsp;the grant of additional options, restricted
stock units or other equity awards under the Company&#8217;s existing equity incentive plans, (ii)&nbsp;changes in the number of outstanding Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities
exercisable for, or convertible into, Common Stock outstanding on the date hereof, (iii)&nbsp;as a result of the issuance of Placement Shares, (iv)&nbsp;any repurchases of capital stock of the Company, (v)&nbsp;as described in a proxy statement
filed on Schedule 14A or a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4,</FONT> (vi)&nbsp;securities offered and sold pursuant to the Registration Statement, or (vii)&nbsp;otherwise publicly announced) and such authorized
capital stock conforms to the description thereof set forth in the Registration Statement and the Prospectus. The description of the Common Stock in the Registration Statement and the Prospectus is complete and accurate in all material respects.
Except as disclosed in or contemplated by the Registration Statement or the Prospectus, the Company did not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or
exchangeable for, or any contracts or commitments to issue or sell, any shares of capital stock or other securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">k. <U><FONT
STYLE="white-space:nowrap">S-3</FONT> Eligibility</U>. (i)&nbsp;At the time of filing the Registration Statement and (ii)&nbsp;at the time of the most recent amendment thereto for the purposes of complying with Section&nbsp;10(a)(3) of the
Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section&nbsp;13 or 15(d) of the Exchange Act or form of prospectus), the Company met the then applicable requirements for use of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, including compliance with General Instruction I.B.1 of Form <FONT STYLE="white-space:nowrap">S-3,</FONT> as applicable. The Company is not a shell company (as defined in Rule 405 under
the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in General Instruction I.B of Form <FONT
STYLE="white-space:nowrap">S-3)</FONT> with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">l. <U>Authorization; Enforceability</U>. The Company has full legal right, power and authority to enter into this Agreement and perform the
transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable against the Company in accordance with its terms, except to the
extent that (i)&nbsp;enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general equitable principles and (ii)&nbsp;the indemnification and
contribution provisions of <U>Section</U><U></U><U>&nbsp;11</U> hereof may be limited by federal or state securities laws and public policy considerations in respect thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">m. <U>Authorization of Placement Shares</U>. The Placement Shares, when issued and delivered pursuant to the terms approved by the board of
directors of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, will be duly and validly authorized and issued and fully paid and nonassessable, free and clear
of any pledge, lien, encumbrance, security interest or other claim (other than any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pledge, lien, encumbrance, security interest or other claim arising from an act or omission of an Agent or a purchaser), including any statutory or contractual preemptive rights, resale rights,
rights of first refusal or other similar rights, and will be registered pursuant to Section&nbsp;12 of the Exchange Act. The Placement Shares, when issued, will conform in all material respects to the description thereof set forth in or incorporated
into the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">n. <U>No Consents Required</U>. No consent, approval, authorization, order, registration or qualification of or with
any court or arbitrator or any governmental or regulatory authority having jurisdiction over the Company is required for the execution, delivery and performance by the Company of this Agreement, and the issuance and sale by the Company of the
Placement Shares as contemplated hereby, except for such consents, approvals, authorizations, orders and registrations or qualifications (i)&nbsp;as may be required under applicable state securities laws or by the
<FONT STYLE="white-space:nowrap">by-laws</FONT> and rules of the Financial Industry Regulatory Authority (&#8220;<U>FINRA</U>&#8221;) or the Exchange, including any notices that may be required by the Exchange, in connection with the sale of the
Placement Shares by the Agents, (ii)&nbsp;as may be required under the Securities Act and (iii)&nbsp;as have been previously obtained by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">o. <U>No Preferential Rights</U>. (i)&nbsp;No person, as such term is defined in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated under the Securities Act (each, a &#8220;<U>Person</U>&#8221;), has the right, contractual or otherwise, to cause the Company to issue or sell to such Person any Common Stock or
shares of any other capital stock or other securities of the Company (other than upon the vesting of restricted stock units or exercise of options or warrants to purchase Common Stock or upon the vesting of restricted stock units or exercise of
options that may be granted from time to time under the Company&#8217;s equity incentive plans), (ii) no Person has any preemptive rights, rights of first refusal, or any other rights (whether pursuant to a &#8220;poison pill&#8221; provision or
otherwise) to purchase any Common Stock or shares of any other capital stock or other securities of the Company from the Company which have not been duly waived or satisfied with respect to the offering contemplated hereby, (iii)&nbsp;no Person has
the right to act as an underwriter or as a financial advisor to the Company in connection with the offer and sale of the Placement Shares, except as contemplated by this Agreement, and (iv)&nbsp;no Person has the right, contractual or otherwise, to
require the Company to register under the Securities Act any Common Stock or shares of any other capital stock or other securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering
contemplated thereby, whether as a result of the filing or effectiveness of the Registration Statement or the sale of the Placement Shares as contemplated thereby or otherwise, except in each case for such rights as have been waived or satisfied on
or prior to the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">p. <U>Independent Public Accountant</U>. Grant Thornton LLP (the &#8220;<U>Accountant</U>&#8221;), whose
report on the consolidated financial statements of the Company is filed with the Commission as part of the Company&#8217;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed with the Commission and incorporated into
the Registration Statement, is and, during the periods covered by its report, were independent public accountants within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company&#8217;s
knowledge, such Accountant is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the &#8220;<U>Sarbanes-Oxley Act</U>&#8221;) with respect to the Company and with respect to the periods covered by their
report. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">q. <U>Enforceability of Agreements</U>. To the Company&#8217;s knowledge, all agreements
between the Company and third parties expressly referenced in the Prospectus, other than such agreements that have expired by their terms or whose termination is disclosed in documents filed by the Company on EDGAR, are legal, valid and binding
obligations of the Company and enforceable in accordance with their respective terms, except to the extent that (i)&nbsp;enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217;
rights generally and by general equitable principles and (ii)&nbsp;the indemnification provisions of certain agreements may be limited by federal or state securities laws or public policy considerations in respect thereof, and except for any
unenforceability that, individually or in the aggregate, would not have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">r. <U>No Litigation</U>. There are no
legal, governmental or regulatory actions, suits or proceedings pending, nor, to the Company&#8217;s knowledge, any legal, governmental or regulatory investigations, including any proceeding before the United States Food and Drug Administration of
the U.S. Department of Health and Human Services (the &#8220;<U>FDA</U>&#8221;) or comparable federal, state, local or foreign governmental authorities (it being understood that the interaction between the Company and the FDA and such comparable
governmental authorities relating to the clinical development and product approval process shall not be deemed proceedings for purposes of this representation), to which the Company or a Subsidiary is a party or to which any property of the Company
or any Subsidiary is the subject that, individually or in the aggregate, if determined adversely to the Company or any Subsidiary, would have a Material Adverse Effect or materially and adversely affect the ability of the Company to perform its
obligations under this Agreement; to the Company&#8217;s knowledge, no such actions, suits or proceedings are threatened or contemplated by any governmental or regulatory authority or threatened by others that, individually or in the aggregate, if
determined adversely to the Company or any Subsidiary, would have a Material Adverse Effect; and there are no current or pending legal, governmental or regulatory actions, suits, proceedings or, to the Company&#8217;s knowledge, investigations that
are required under the Securities Act to be described in the Prospectus that are not described in the Prospectus (including any Incorporated Document). The Company is in compliance with all applicable federal, state, local and foreign laws,
regulations, orders and decrees governing its business as enforced by the FDA, or any other federal, state or foreign agencies or bodies engaged in the regulation of medical devices, except where noncompliance would not, singularly or in the
aggregate, reasonably be expected to have a Material Adverse Effect. All preclinical and clinical studies conducted by or on behalf of the Company to support clearance for commercialization of the Company&#8217;s products have been conducted by the
Company, or to the Company&#8217;s knowledge by third parties, in compliance with all applicable federal, state or foreign laws, rules, orders and regulations, except for such failure or failures to be in compliance as would not reasonably be
expected to have, singularly or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">s. <U>Licenses and Permits</U>. The Company and the
Subsidiaries possess or have obtained, all licenses, certificates, consents, orders, approvals, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign
governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as currently conducted, as described in the Registration Statement and the Prospectus
(the &#8220;<U>Permits</U>&#8221;), except where the failure to possess, obtain or make the same would not, individually or in the aggregate, have a Material Adverse Effect. Neither the Company nor any Subsidiary has received written notice of any
proceeding relating to revocation or modification of any such Permit or has any reason to believe that such Permit will not be renewed in the ordinary course, except where the failure to obtain any such renewal would not, individually or in the
aggregate, have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">t. <U>No Material Defaults</U>. Neither the Company nor any Subsidiary has defaulted on any
installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect. The Company has not filed a report pursuant to
Section&nbsp;13(a) or 15(d) of the Exchange Act since the filing of its last Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> indicating that it (i)&nbsp;has failed to pay any dividend or sinking fund installment on preferred
stock or (ii)&nbsp;has defaulted on any installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">u. <U>Certain Market Activities</U>. Neither the Company, nor any Subsidiary, nor, to the knowledge of the Company, any of their respective
directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the Placement Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">v. <U>Broker/Dealer Relationships</U>. Neither the
Company nor any Subsidiary or any related entities (i)&nbsp;is required to register as a &#8220;broker&#8221; or &#8220;dealer&#8221; in accordance with the provisions of the Exchange Act or (ii)&nbsp;directly or indirectly through one or more
intermediaries, controls or is a &#8220;person associated with a member&#8221; or &#8220;associated person of a member&#8221; (within the meaning set forth in the FINRA Manual). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">w. <U>No Reliance</U>. The Company has not relied upon any Agent or legal counsel for the Agents for any legal, tax or accounting advice in
connection with the offering and sale of the Placement Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">x. <U>Taxes</U>. The Company and the Subsidiaries have filed all federal,
state, local and foreign tax returns which have been required to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to
do so would not have a Material Adverse Effect. Except as otherwise disclosed in or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined adversely to the Company or any Subsidiary which has had, or
would have, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been or might be asserted or threatened against it
which would have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">y. <U>Title to Real and Personal Property.</U> The Company and the Subsidiaries have good and
valid title in fee simple to all items of real property and good and valid title to all personal property described in the Registration Statement or Prospectus as being owned by them that are material to the businesses of the Company or such
Subsidiary, in each case free and clear of all liens, encumbrances and claims, except those that (i)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries or (ii)&nbsp;would
not, individually or in the aggregate, have a Material Adverse Effect. Any real property described in the Registration Statement or Prospectus as being leased by the Company and the Subsidiaries is held by them under valid, existing and enforceable
leases, except those that (A)&nbsp;do not materially interfere with the use made or proposed to be made of such property by the Company or the Subsidiaries or (B)&nbsp;would not, individually or in the aggregate, have a Material Adverse Effect. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">z. <U>Intellectual Property</U>. The Company and the Subsidiary own or possess adequate
enforceable rights to use all patents, patent applications, trademarks (both registered and unregistered), trade names, trademark registrations, service marks, service mark registrations, Internet domain name registrations, copyrights, copyright
registrations, licenses and <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures) (collectively, the &#8220;<U>Intellectual
Property</U>&#8221;), necessary for the conduct of their respective businesses as conducted as of the date hereof, except to the extent that the failure to own or possess adequate rights to use such Intellectual Property would not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and the Subsidiaries have not received any written notice of any credible claim of infringement or conflict which asserted Intellectual Property rights of
others, which infringement or conflict, if the subject of an unfavorable decision, would result in a Material Adverse Effect. There are no pending, or to the Company&#8217;s knowledge, threatened judicial proceedings or interference proceedings
challenging the Company&#8217;s or any Subsidiary&#8217;s rights in or to or the validity of the scope of any of the Company&#8217;s or its Subsidiaries&#8217; patents, patent applications or proprietary information. No other entity or individual
has any right or claim in any of the Company&#8217;s or any of its Subsidiary&#8217;s patents, patent applications or any patent to be issued therefrom by virtue of any contract, license or other agreement entered into between such entity or
individual and the Company or any Subsidiary or by any <FONT STYLE="white-space:nowrap">non-contractual</FONT> obligation, other than by written licenses granted by the Company or any Subsidiary, except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect. The Company has not received any written notice of any credible claim challenging the rights of the Company or its Subsidiaries in or to any Intellectual Property owned, licensed
or optioned by the Company or any Subsidiary which claim, if the subject of an unfavorable decision, would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">aa. <U>Compliance with Applicable Laws</U>. The Company and the Subsidiaries: (A)&nbsp;are and at all times have been in material compliance
with all statutes, rules and regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any
product under development, manufactured or distributed by the Company or the Subsidiaries (&#8220;<U>Applicable Laws</U>&#8221;), (B) have not received any Form 483 from the FDA, notice of adverse finding, warning letter, or other written
correspondence or notice from the FDA, the European Medicines Agency (the &#8220;<U>EMA</U>&#8221;), or any other federal, state, local or foreign governmental or regulatory authority alleging or asserting material noncompliance with any Applicable
Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (&#8220;<U>Authorizations</U>&#8221;), which would, individually or in the aggregate,
result in a Material Adverse Effect; (C)&nbsp;possess all material Authorizations and such Authorizations are valid and in full force and effect and neither the Company nor the Subsidiaries is in material violation of any term of any such
Authorizations; (D)&nbsp;have not received written notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from the FDA, the EMA, or any other federal, state, local
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or foreign governmental or regulatory authority or third party alleging that any Company product, operation or activity is in material violation of any Applicable Laws or Authorizations and has
no knowledge that the FDA, the EMA, or any other federal, state, local or foreign governmental or regulatory authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding against the
Company; (E)&nbsp;have not received written notice that the FDA, EMA, or any other federal, state, local or foreign governmental or regulatory authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any material
Authorizations and has no knowledge that the FDA, EMA, or any other federal, state, local or foreign governmental or regulatory authority is considering such action; and (F)&nbsp;have filed, obtained, maintained or submitted all reports, documents,
forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations except where the failure to file such reports, documents, forms, notices, applications, records, claims,
submissions and supplements or amendments would not result in a Material Adverse Effect, and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and
correct on the date filed (or were corrected or supplemented by a subsequent submission). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">bb. <U>Compliance Program</U>. The Company has
established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those
administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be
expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">cc. <U>Clinical Studies</U>. The animal and other preclinical studies and clinical trials
conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company&#8217;s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols,
procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new medical devices as applied to comparable products to those being developed by the Company; the descriptions of the results of such
preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no
knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed
in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or
modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the
Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">dd. <U>Environmental Laws</U>. The Company and the Subsidiaries (i)&nbsp;are in compliance
with any and all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or
contaminants (collectively, &#8220;<U>Environmental </U><U>Laws</U>&#8221;); (ii)&nbsp;have received and are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses as described in the Registration Statement and the Prospectus; and (iii)&nbsp;have not received notice of any actual or potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances
or wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or (iii)&nbsp;above, for any such failure to comply or failure to receive required permits, licenses, other approvals or liability as would not, individually or
in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">ee. <U>Disclosure Controls</U>. The Company maintains a system of internal accounting
controls designed to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of the
Company&#8217;s consolidated financial statements in accordance with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv)&nbsp;the
recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware of any material weaknesses in its internal control over
financial reporting (other than as set forth in the Registration Statement or the Prospectus). Since the date of the latest audited financial statements of the Company included or incorporated by reference in the Prospectus, there has been no change
in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting (other than as set forth in the Registration
Statement or the Prospectus). The Company has established disclosure controls and procedures (as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15)</FONT> that comply with the
requirements of the Exchange Act. The Company&#8217;s certifying officers have evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of a date within 90 days prior to the filing date of the Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year most recently ended (such date, the &#8220;<U>Evaluation Date</U>&#8221;). The Company presented in its <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year most
recently ended the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the most recent Evaluation Date, and the &#8220;disclosure controls and procedures&#8221;
are effective (other than as set forth in the Registration Statement or the Prospectus). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">ff. <U>Sarbanes-Oxley Act</U>. There is and has
been no failure on the part of the Company or, to the knowledge of the Company, any of the Company&#8217;s directors or officers, in their capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley
Act and the rules and regulations promulgated thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial
officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it
to the Commission during the past 12 months. For purposes of the preceding sentence, &#8220;principal executive officer&#8221; and &#8220;principal financial officer&#8221; shall have the meanings given to such terms in the Exchange Act Rules <FONT
STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">gg. <U>Finder&#8217;s Fees</U>. Neither the Company nor any Subsidiary has incurred any
liability for any finder&#8217;s fees, brokerage commissions or similar payments in connection with the transactions herein contemplated, except as may otherwise exist with respect to the Agents pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">hh. <U>Labor Disputes</U>. No labor disturbance by or dispute with employees of the Company or any Subsidiary exists or, to the knowledge of
the Company, is threatened which would result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">ii. <U>Investment Company Act</U>. Neither the Company nor
any Subsidiary is or, after giving effect to the offering and sale of the Placement Shares, will be required to register as an &#8220;investment company&#8221; or an entity &#8220;controlled&#8221; by an &#8220;investment company,&#8221; as such
terms are defined in the Investment Company Act of 1940, as amended (the &#8220;<U>Investment Company Act</U>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">jj.
<U>Operations</U>. The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act
of 1970, as amended, the money laundering statutes of all jurisdictions to which the Company or the Subsidiaries are subject, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or
enforced by any governmental agency having jurisdiction over the Company (collectively, the &#8220;<U>Money Laundering Laws</U>&#8221;), except where the failure to be in such compliance would not result in a Material Adverse Effect; and no action,
suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">kk. <U><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements</U>. There are no transactions, arrangements and other
relationships between and/or among the Company, and/or, to the knowledge of the Company, any of its affiliates and any unconsolidated entity, including, but not limited to, any structured finance, special purpose or limited purpose entity (each, an
&#8220;<U>Off Balance Sheet Transaction</U>&#8221;) that would affect materially the Company&#8217;s liquidity or the availability of or requirements for its capital resources, including those Off Balance Sheet Transactions described in the
Commission&#8217;s Statement about Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations (Release Nos. <FONT STYLE="white-space:nowrap">33-8056;</FONT> <FONT STYLE="white-space:nowrap">34-45321;</FONT> <FONT
STYLE="white-space:nowrap">FR-61),</FONT> required to be described in the Registration Statement or the Prospectus which have not been described as required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">ll. <U>Underwriter Agreements</U>. Other than with respect to this Agreement and the Original Agreement, the Company is not a party to any
agreement with an agent or underwriter for any other &#8220;at the market&#8221; or continuous equity transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">mm. <U>ERISA</U>. To
the knowledge of the Company, (i)&nbsp;each material employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;<U>ERISA</U>&#8221;) that is maintained, administered or
contributed to by the Company or any of its affiliates for employees or former employees of the Company and the Subsidiaries has been maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and
regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the &#8220;<U>Code</U>&#8221;); (ii) no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has
occurred which would result in a material liability to the Company with respect to any such plan excluding transactions effected pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a statutory or administrative exemption; and (iii)&nbsp;for each such plan that is subject to the funding rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, no &#8220;accumulated
funding deficiency&#8221; as defined in Section&nbsp;412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) equals or
exceeds the present value of all benefits accrued under such plan determined using reasonable actuarial assumptions, other than, in the case of (i), (ii) and (iii)&nbsp;above, as would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">nn. <U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section&nbsp;27A of the Securities Act and
Section&nbsp;21E of the Exchange Act) (a&nbsp;&#8220;<U>Forward-Looking Statement</U>&#8221;) contained in the Registration Statement and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good
faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">oo. <U>Margin Rules</U>. Neither the issuance, sale and delivery of the Placement Shares nor the application of the proceeds
thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">pp. <U>Insurance</U>. The Company and the Subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as the
Company and the Subsidiaries reasonably believe are adequate for the conduct of their business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">qq. <U>No Improper Practices</U>.
(i)&nbsp;Neither the Company nor, to the Company&#8217;s knowledge, the Subsidiaries, nor to the Company&#8217;s knowledge, any of their respective executive officers has, in the past five years, made any unlawful contributions to any candidate for
any political office (or failed fully to disclose any contribution in violation of law) or made any contribution or other payment to any official of, or candidate for, any federal, state, municipal, or foreign office or other person charged with
similar public or quasi-public duty in violation of any law or of the character required to be disclosed in the Prospectus; (ii)&nbsp;no relationship, direct or indirect, exists between or among the Company or, to the Company&#8217;s knowledge, the
Subsidiaries or any affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or, to the Company&#8217;s knowledge, the Subsidiaries, on the other hand, that is required by the Securities Act to be
described in the Registration Statement and the Prospectus that is not so described; (iii)&nbsp;no relationship, direct or indirect, exists between or among the Company or the Subsidiaries or any affiliate of them, on the one hand, and the
directors, officers, stockholders or directors of the Company or, to the Company&#8217;s knowledge, the Subsidiaries, on the other hand, that is required by the rules of FINRA to be described in the Registration Statement and the Prospectus that is
not so described; (iv)&nbsp;there are no material outstanding loans or advances or material guarantees of indebtedness by the Company or, to the Company&#8217;s knowledge, the Subsidiaries to or for the benefit of any of their respective officers or
directors or any of the members of the families of any of them; and (v)&nbsp;the Company has not offered, or caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (A)&nbsp;a customer or supplier of
the Company or the Subsidiaries to alter the customer&#8217;s or supplier&#8217;s level or type of business with the Company or the Subsidiaries or (B)&nbsp;a trade journalist or publication to write or publish favorable information about the
Company or the Subsidiaries or any of their respective products or services, and, (vi)&nbsp;neither the Company nor the Subsidiaries nor, to the Company&#8217;s knowledge, any employee or agent of the Company or the Subsidiaries has made any payment
of funds of the Company or the Subsidiaries or received or retained any funds in violation of any law, rule or regulation (including, without limitation, the Foreign Corrupt Practices Act of 1977), which payment, receipt or retention of funds is of
a character required to be disclosed in the Registration Statement or the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">rr. <U>Status Under the Securities Act</U>. The Company was not and is not an ineligible
issuer as defined in Rule 405 under the Securities Act at the times specified in Rules&nbsp;164 and 433 under the Securities Act in connection with the offering of the Placement Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">ss. <U>No Misstatement or Omission in an Issuer Free Writing Prospectus</U>. Each Issuer Free Writing Prospectus, as of its issue date and as
of each Applicable Time (as defined in <U>Section</U><U></U><U>&nbsp;25</U> below), did not, does not and will not, through the completion of the Placement or Placements for which such Issuer Free Writing Prospectus is issued, include any
information that conflicted, conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any incorporated document deemed to be a part thereof that has not been superseded or modified. The
foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by the Agents specifically for use therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">tt. <U>No Conflicts</U>. Neither the execution of this Agreement, nor the issuance, offering or sale of the Placement Shares, nor the
consummation of any of the transactions contemplated herein, nor the compliance by the Company with the terms and provisions hereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or will
constitute a default under, or has resulted in or will result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any contract or other agreement to which the Company
may be bound or to which any of the property or assets of the Company is subject, except (i)&nbsp;such conflicts, breaches or defaults as may have been waived and (ii)&nbsp;such conflicts, breaches and defaults that would not have a Material Adverse
Effect; nor will such action result (x)&nbsp;in any violation of the provisions of the organizational or governing documents of the Company, or (y)&nbsp;in any material violation of the provisions of any statute or any order, rule or regulation
applicable to the Company or of any court or of any federal, state or other regulatory authority or other government body having jurisdiction over the Company, except where such violation would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">uu. <U>OFAC</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Neither
the Company nor any Subsidiary (collectively, the &#8220;<U>Entity</U>&#8221;) nor any director or officer of the Entity nor, to the Company&#8217;s knowledge, any employee, agent, affiliate or representative of the Entity, is a government,
individual, or entity (in this paragraph (uu), &#8220;<U>Person</U>&#8221;) that is, or is owned or controlled by a Person that is: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) the subject of any sanctions administered or enforced by the U.S. Department of Treasury&#8217;s Office of Foreign Assets
Control (&#8220;<U>OFAC</U>&#8221;), the United Nations Security Council (&#8220;<U>UNSC</U>&#8221;), the European Union (&#8220;<U>EU</U>&#8221;), His Majesty&#8217;s Treasury (&#8220;<U>HMT</U>&#8221;), or other relevant sanctions authority
(collectively, &#8220;<U>Sanctions</U>&#8221;), nor </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) located, organized or resident in a country or territory that is
the subject of Sanctions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Entity will not, directly or indirectly, knowingly use the proceeds of the
offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of
such funding or facilitation, is the subject of Sanctions; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) in any other manner that will result in a violation of
Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Entity represents and covenants that, except as detailed in the Registration Statement and the Prospectus, for the past 5 years, it
has not knowingly engaged in and is not now knowingly engaged in any dealing or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">vv. <U>Stock Transfer Taxes</U>. On each Settlement Date, all material stock transfer or other taxes (other than income taxes) which are
required to be paid in connection with the sale and transfer of the Placement Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes will be or will have been fully complied
with by the Company in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">ww. <U>IT Systems</U>. (i)(x) To the knowledge of Company, there has been no security
breach or other compromise of any Company&#8217;s information technology and computer systems, networks, hardware, software, data (including the data of their respective customers, employees, suppliers, vendors and any third party data maintained by
or on behalf of them), equipment or technology (collectively, &#8220;<U>IT Systems and Data</U>&#8221;) and (y)&nbsp;the Company has not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in,
any security breach or other compromise to their IT Systems and Data; (ii)&nbsp;the Company is presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or
governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or
modification, except as would not, in the case of this clause (i)&nbsp;or (ii), individually or in the aggregate, have a Material Adverse Effect; and (iii)&nbsp;the Company has implemented backup and disaster recovery technology consistent with
industry standards and practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any certificate signed by an officer of the Company and delivered to the Agents or to counsel for the
Agents pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to the Agents as to the matters set forth therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Covenants of the Company</U>. The Company covenants and agrees with the Agents that:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Registration Statement Amendments</U>. After the date of this Agreement and during any period in which a prospectus relating to any
Placement Shares is required to be delivered by the Agents under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act) (the &#8220;<U>Prospectus Delivery
Period</U>&#8221;) (i) the Company will notify the Agents promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference or amendments not related to any Placement, has been filed
with the Commission and/or has become effective or any subsequent supplement to the Prospectus, other than documents incorporated by reference or supplements not related to any Placement, has been filed and of any request by the Commission for any
amendment or supplement to the Registration Statement or Prospectus related to the Placement or for additional information related to the Placement, (ii)&nbsp;the Company will prepare and file with the Commission, promptly upon the Agents&#8217;
request, any amendments or supplements to the Registration Statement or Prospectus that, upon the advice of the Company&#8217;s legal counsel, may be necessary or advisable in connection with the distribution of the Placement Shares by the Agents
(<I>provided, however</I>, that the failure of the Agents to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Agents&#8217; right to rely on the representations and warranties made by the
Company in this Agreement and provided, further, that the only remedy the Agents shall have with respect to the failure to make such filing shall be to cease making sales under this Agreement until such amendment or supplement is filed); (iii) the
Company will not file any amendment or supplement to the Registration Statement or Prospectus relating to the Placement Shares or a security convertible into the Placement Shares (other than an Incorporated Document) unless a copy thereof has been
submitted to the Agents within a reasonable period of time before the filing and the Agents have not reasonably objected thereto (<I>provided, however</I>, that (A)&nbsp;the failure of the Agents to make such objection shall not relieve the Company
of any obligation or liability hereunder, or affect the Agents&#8217; right to rely on the representations and warranties made by the Company in this Agreement and (B)&nbsp;the Company has no obligation to provide the Agents any advance copy of such
filing or to provide the Agents an opportunity to object to such filing if the filing does not name the Agents or does not relate to the transaction herein provided; and provided, further, that the only remedy the Agents shall have with respect to
the failure by the Company to obtain such consent shall be to cease making sales under this Agreement) and the Company will furnish to the Agents at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by
reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; and (iv)&nbsp;the Company will cause each amendment or supplement to the Prospectus to be filed with the Commission as required pursuant to the
applicable paragraph of Rule 424(b) of the Securities Act or, in the case of any document to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed (the
determination to file or not file any amendment or supplement with the Commission under this <U>Section</U><U></U><U>&nbsp;7(a)</U>, based on the Company&#8217;s reasonable opinion or reasonable objections, shall be made exclusively by the Company).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>Notice of Commission Stop Orders</U>. The Company will advise the Agents, promptly after it receives notice or obtains knowledge
thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction,
or of the initiation or threatening of any proceeding for any such purpose; and it will use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. The Company
will advise the Agents promptly after it receives any request by the Commission for any amendments to the Registration Statement or any amendment or supplements to the Prospectus or any Issuer Free Writing Prospectus or for additional information
related to the offering of the Placement Shares or for additional information related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>Delivery of Prospectus; Subsequent Changes</U>. During the Prospectus Delivery Period,
the Company will comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports and any definitive proxy or information statements required to be
filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If the Company has omitted any information from the Registration Statement pursuant to Rule 430A under the
Securities Act, it will use its commercially reasonable efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430A and to notify the Agents promptly of all such filings. If during the
Prospectus Delivery Period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the
light of the circumstances then existing, not misleading, or if during such Prospectus Delivery Period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly
notify the Designated Agent to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or
omission or effect such compliance; <I>provided, however</I>, that the Company may delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. <U>Listing of Placement Shares</U>. During the Prospectus Delivery Period, the Company will use its commercially reasonable efforts to
cause the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions in the United States as the Agents reasonably designate and to continue such qualifications in
effect so long as required for the distribution of the Placement Shares; <I>provided, however</I>, that the Company shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities, file a general consent to
service of process, or subject itself to taxation in any jurisdiction if it is not otherwise so subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Delivery of Registration
Statement and Prospectus</U>. The Company will furnish to the Agents and their counsel (at the reasonable expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and
all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during the Prospectus Delivery Period (including all documents filed with the Commission during such period that are deemed to be
incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as the Agents may from time to time reasonably request and, at the Agents&#8217; request, will also furnish copies of the Prospectus to each
exchange or market on which sales of the Placement Shares may be made; <I>provided, however</I>, that the Company shall not be required to furnish any document (other than the Prospectus) to the Agents to the extent such document is available on
EDGAR. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <U>Earnings Statement</U>. The Company will make generally available to its security
holders as soon as practicable, but in any event not later than 15 months after the end of the Company&#8217;s current fiscal quarter, an earnings statement covering a <FONT STYLE="white-space:nowrap">12-month</FONT> period that satisfies the
provisions of Section&nbsp;11(a) and Rule 158 of the Securities Act. The Company shall be deemed to have satisfied this Section&nbsp;7(f) through public filings made by the Company using the EDGAR system. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. <U>Use of Proceeds</U>. The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#8220;Use of
Proceeds.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. <U>Notice of Other Sales</U>. Without the prior written consent of the Agents, the Company will not, directly or
indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common
Stock, warrants or any rights to purchase or acquire, Common Stock during the period beginning on the date on which any Placement Notice is delivered to the Agents hereunder and ending on the third (3rd) Trading Day immediately following the final
Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date of such
suspension or termination); and will not directly or indirectly in any other &#8220;at the market&#8221; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other
than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock prior to the termination of this Agreement; <I>provided,
however</I>, that such restrictions will not apply in connection with the Company&#8217;s issuance or sale of (i)&nbsp;Common Stock, restricted stock units, options to purchase Common Stock or Common Stock issuable upon the vesting of restricted
stock units or the exercise of options, pursuant to any restricted stock unit, stock option, equity incentive plan, employee stock purchase plan, benefits plan, stock ownership plan or dividend reinvestment plan (but not Common Stock subject to a
waiver to exceed plan limits in its dividend reinvestment plan) of the Company whether now in effect or hereafter implemented; (ii)&nbsp;Common Stock issuable upon conversion of securities or the exercise of warrants, options or other rights in
effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to the Agents, (iii)&nbsp;Common Stock, or securities convertible into or exercisable for Common Stock, offered and sold in a privately
negotiated transaction to vendors, customers, strategic partners or potential strategic partners or other investors conducted in a manner so as not to be integrated with the offering of Common Stock hereby and (iv)&nbsp;Common Stock or securities
convertible into or exercisable for Common Stock, offered in connection with any acquisition, strategic investment or other similar transaction (including any joint venture, strategic alliance or partnership). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. <U>Change of Circumstances</U>. The Company will, at any time during the pendency of a Placement Notice advise the Agents promptly after it
shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document required to be provided to the Agents pursuant to this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">j. <U>Due Diligence Cooperation</U>. During the term of this Agreement, the Company will cooperate with any reasonable due
diligence review conducted by the Agents or their representatives in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during
regular business hours and at the Company&#8217;s principal offices, as the Agents may reasonably request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">k. <U>Required Filings Relating to Placement of Placement Shares</U>. The Company agrees
that on such dates as the Securities Act shall require, the Company will (i)&nbsp;file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (each and every date a filing under Rule 424(b)
is made, a &#8220;<U>Filing Date</U>&#8221;), which prospectus supplement will set forth, within the relevant period, the amount of Placement Shares sold through the Agents, the Net Proceeds to the Company and the compensation payable by the Company
to the Agents with respect to such Placement Shares (provided that the Company may satisfy its obligations under this Section&nbsp;7(k)(i) by making a filing in accordance with the Exchange Act including such information), and (ii)&nbsp;deliver such
number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">l. <U>Representation Dates; Certificate</U>. Each time during the term of this Agreement that the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) amends or supplements (other than a prospectus supplement relating solely to an offering of securities other than the Placement Shares)
the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration Statement or the
Prospectus relating to the Placement Shares; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) files an annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> under the
Exchange Act (including any Form <FONT STYLE="white-space:nowrap">10-K/A</FONT> containing amended audited financial information or a material amendment to the previously filed Form <FONT STYLE="white-space:nowrap">10-K);</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) files its quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> under the Exchange Act; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) files a current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> containing amended financial information (other than
information &#8220;furnished&#8221; pursuant to Items 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K</FONT> or to provide disclosure pursuant to Item 8.01 of Form <FONT STYLE="white-space:nowrap">8-K</FONT> relating to the
reclassification of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No.&nbsp;144) under the Exchange Act; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Each date of filing of one or more of the documents referred to in clauses (i)&nbsp;through (iv) shall be a &#8220;<U>Representation Date</U>.&#8221;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Company shall furnish the Agents (but in the case of clause (iv)&nbsp;above only if any Agent reasonably determines that the information contained in such
Form <FONT STYLE="white-space:nowrap">8-K</FONT> is material) with a certificate, in the form attached hereto as <U>Exhibit 7(1)</U>. The requirement to provide a certificate under this <U>Section</U><U></U><U>&nbsp;7(1)</U> shall be waived for any
Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be
considered a Representation Date) and the next occurring Representation Date on which the Company files its annual report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> Notwithstanding the foregoing, (i)&nbsp;upon the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
delivery of the first Placement Notice hereunder and (ii)&nbsp;if the Company subsequently decides to sell Placement Shares following a Representation Date when the Company relied on such waiver
and did not provide the Agents with a certificate under this <U>Section</U><U></U><U>&nbsp;7(1)</U>, then before the Agents sell any Placement Shares, the Company shall provide the Agents with a certificate, in the form attached hereto as <U>Exhibit
7(1)</U>, dated the date of the Placement Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">m. <U>Legal Opinion</U>. On or prior to the date of the first Placement Notice given
hereunder the Company shall cause to be furnished to the Agents a written opinion and a negative assurance letter of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (&#8220;<U>Company Counsel</U>&#8221;), or other counsel reasonably satisfactory
to the Agents, each in form and substance reasonably satisfactory to the Agents. Thereafter, within five (5)&nbsp;Trading Days of each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached
hereto as Exhibit 7(l) for which no waiver is applicable, the Company shall cause to be furnished to the Agents a&nbsp;negative assurance letter of Company Counsel in form and substance reasonably satisfactory to the Agents; provided that, in lieu
of such negative assurance letters for subsequent periodic filings under the Exchange Act, counsel may furnish the Agents with a letter (a&nbsp;&#8220;<U>Reliance Letter</U>&#8221;) to the effect that the Agents may rely on the negative assurance
letter previously delivered under this Section&nbsp;7(m) to the same extent as if it were dated the date of such letter (except that statements in such prior letter shall be deemed to relate to the Registration Statement and the Prospectus as
amended or supplemented as of the date of the Reliance Letter). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">n. <U>Comfort Letter</U>. On or prior to the date of the first Placement
Notice given hereunder and within five (5)&nbsp;Trading Days after each subsequent Representation Date, other than pursuant to Section&nbsp;7(l)(iii), the Company shall cause its independent accountant to furnish the Agents a letter (the
&#8220;<U>Comfort Letter</U>&#8221;), dated the date the Comfort Letter is delivered, which shall meet the requirements set forth in this <U>Section</U><U></U><U>&nbsp;7(n)</U>. The Comfort Letter from the Company&#8217;s independent accountants
shall be in a form and substance reasonably satisfactory to the Agents, (i)&nbsp;confirming that it is an independent public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (the
&#8220;<U>PCAOB</U>&#8221;), (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters
in connection with registered public offerings (the first such letter, the &#8220;<U>Initial Comfort Letter</U>&#8221;) and (iii)&nbsp;updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort
Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">o. <U>Market Activities</U>. The Company will not, directly or indirectly, (i)&nbsp;take any action designed to cause or result in, or that
constitutes or would constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii)&nbsp;sell, bid for, or purchase Common Stock in violation of Regulation M, or pay
anyone any compensation for soliciting purchases of the Placement Shares other than the Agents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">p. <U>Investment Company Act</U>. The
Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor the Subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined
in the Investment Company Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">q. <U>No Offer to Sell</U>. Other than an Issuer Free Writing Prospectus approved in advance
by the Company and the Agents in their capacity as agents hereunder pursuant to <U>Section</U><U></U><U>&nbsp;23</U>, neither of the Agents nor the Company (including its agents and representatives, other than the Agents in their capacity as such)
will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">r. <U>Sarbanes-Oxley Act</U>. The Company will maintain and keep accurate books and records reflecting its assets and maintain internal
accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and including those policies and
procedures that (i)&nbsp;pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (ii)&nbsp;provide reasonable assurance that transactions are
recorded as necessary to permit the preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP, (iii)&nbsp;that receipts and expenditures of the Company are being made only in accordance with management&#8217;s and
the Company&#8217;s directors&#8217; authorization, and (iv)&nbsp;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect
on its financial statements. The Company will use commercially reasonable efforts to maintain disclosure controls and procedures that comply with the requirements of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Representations and Covenants of the Agents</U>. Each of the Agents represents and warrants that it is duly registered as a
broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which such Agent is exempt from registration or such registration is
not otherwise required. Each of the Agents shall continue, for the term of this Agreement, to be duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares
will be offered and sold, except such states in which it is exempt from registration or such registration is not otherwise required, during the term of this Agreement. Each of the Agents shall comply with all applicable law and regulations in
connection with the transactions contemplated by this Agreement, including the issuance and sale through such Agent of the Placement Shares, including, but not limited to, Regulation M under the Exchange Act. During the term of this Agreement,
neither the Agents nor an affiliate purchaser (as such term is defined in Regulation M) shall, directly or indirectly, engage in (i)&nbsp;any short sale of any security of the Company, as defined in Regulation SHO, (ii)&nbsp;any sale of any security
of the Company that the Agents do not own or any sale which is consummated by the delivery of a security of the Company borrowed by, or for the account of, the Agents or (iii)&nbsp;any market making, bidding, stabilization or other trading activity
with regard to the Common Stock or related derivative securities, in each case if such activity would be prohibited under Regulation M or other anti-manipulation rules under the Securities Act or Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Payment of Expenses</U>. The Company will pay all expenses incident to the performance of its obligations under this Agreement,
including (i)&nbsp;the preparation, filing, including any fees required by the Commission, and printing of the Registration Statement (including financial statements and exhibits) as originally filed and of each amendment and supplement thereto and
each Free Writing Prospectus, in such number as the Agents shall deem reasonably necessary, (ii)&nbsp;the printing and delivery to the Agents of this Agreement and such other documents </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as may be required in connection with the offering, purchase, sale, issuance or delivery of the Placement Shares, (iii)&nbsp;the preparation, issuance and delivery of the certificates, if any,
for the Placement Shares to the Agents, including any stock or other transfer taxes and any capital duties, stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement Shares to the Agents, (iv)&nbsp;the fees
and disbursements of the counsel, accountants and other advisors to the Company, (v)&nbsp;the reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and disbursements of counsel
to the Agents (x)&nbsp;not to exceed $75,000 in connection with the filing of this Agreement and (y)&nbsp;not to exceed $5,000 per calendar quarter thereafter in connection with updates at the time of Representation Dates so long as this Agreement
remains in effect and the Agents perform standard quarterly due diligence with the Company for such Representation Dates and excluding any period during which a Suspension is in place pursuant to Section&nbsp;4; (vi) the fees and expenses of the
transfer agent and registrar for the Common Stock, (vii)&nbsp;the filing fees incident to any review by FINRA of the terms of the sale of the Placement Shares, and (viii)&nbsp;the fees and expenses incurred in connection with the listing of the
Placement Shares on the Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Conditions to the Agents&#8217; Obligations</U>. The obligations of the Agents hereunder with
respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein (other than those representations and warranties made as of a specified date or time), to the due
performance in all material respects by the Company of its obligations hereunder, to the completion by the Agents of a due diligence review satisfactory to it in its reasonable judgment, and to the continuing reasonable satisfaction (or waiver by
the Agents in their sole discretion) of the following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. <U>Registration Statement Effective</U>. The Registration
Statement shall remain effective and shall be available for the sale of all Placement Shares contemplated to be issued by any Placement Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. <U>No Material Notices</U>. None of the following events shall have occurred and be continuing: (i)&nbsp;receipt by the Company of any
request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any
<FONT STYLE="white-space:nowrap">post-effective</FONT> amendments or supplements to the Registration Statement or the Prospectus which have not, as of the time of the next Placement or sale of Placement Shares, been so made; (ii)&nbsp;the issuance
by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or receipt by the Company of notification of the initiation of any proceedings for that purpose;
(iii)&nbsp;receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or receipt by the Company of notification of the
initiation of, or a threat to initiate, any proceeding for such purpose; or (iv)&nbsp;the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material Incorporated Document untrue in
any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or any material Incorporated Document so that, in the case of the Registration Statement, it will not contain any materially untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus or any material Incorporated Document, it will not
contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading
which have not, as of the time of the next Placement or sale of Placement Shares, been so made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. <U>No Misstatement or Material Omission</U>. The Agents shall not have advised the
Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Agents&#8217; reasonable opinion is material, or omits to state a fact that in the Agents&#8217;
reasonable opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d.
<U>Material Changes</U>. Except as contemplated in the Prospectus, or disclosed in the Company&#8217;s reports filed with the Commission, there shall not have been any Material Adverse Effect, or any development that would cause a Material Adverse
Effect, or a downgrading in or withdrawal of the rating assigned to any of the Company&#8217;s securities (other than asset backed securities) by any &#8220;nationally recognized statistical rating organization,&#8221; as such term is defined by the
Commission for purposes of Rule 436(g)(2) under the Securities Act (a &#8220;<U>Rating Organization</U>&#8221;), or a public announcement by any Rating Organization that it has under surveillance or review its rating of any of the Company&#8217;s
securities (other than asset backed securities), the effect of which, in the case of any such action by a Rating Organization described above, in the reasonable judgment of the Agents (without relieving the Company of any obligation or liability it
may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. <U>Company Counsel Legal Opinion</U>. The Agents shall have received the opinion and negative assurance letter of Company Counsel required
to be delivered pursuant to <U>Section</U><U></U><U>&nbsp;7(m)</U> on or before the date on which such delivery of such opinion and negative assurance letter are required pursuant to <U>Section</U><U></U><U>&nbsp;7(m)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. <U>Agents Counsel Legal Opinion</U>. Agents shall have received from Duane Morris LLP, counsel for the Agents, such opinion or opinions, on
or before the date on which the delivery of the Company Counsel legal opinion is required pursuant to <U>Section</U><U></U><U>&nbsp;7(m)</U>, with respect to such matters as the Agents may reasonably require, and the Company shall have furnished to
such counsel such documents as they request for enabling them to pass upon such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. <U>Comfort Letter</U>. The Agents shall have
received the Comfort Letter required to be delivered pursuant <U>Section</U><U></U><U>&nbsp;7(n)</U> on or before the date on which such delivery of such letter is required pursuant to <U>Section</U><U></U><U>&nbsp;7(n)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. <U>Representation Certificate</U>. The Agents shall have received the certificate required to be delivered pursuant to
<U>Section</U><U></U><U>&nbsp;7(1)</U> on or before the date on which delivery of such certificate is required pursuant to <U>Section</U><U></U><U>&nbsp;7(1)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. <U>Secretary</U><U>&#8217;</U><U>s Certificate</U>. On or prior to the first Representation Date, the Agents shall have received a
certificate, signed on behalf of the Company by its corporate Secretary, in form and substance reasonably satisfactory to the Agents and their counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">j. <U>No Suspension</U>. Trading in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been
delisted from the Exchange. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">k. <U>Other Materials</U>. On each date on which the Company is required to deliver a
certificate pursuant to <U>Section</U><U></U><U>&nbsp;7(1)</U>, the Company shall have furnished to the Agents such appropriate further information, certificates and documents as the Agents may reasonably request and which are usually and
customarily furnished by an issuer of securities in connection with a securities offering of the type contemplated hereby. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">l. <U>Securities Act Filings Made</U>. All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior
to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">m. <U>Approval for Listing</U>. To the extent required by the continued listing rules of the Exchange, the Placement Shares shall either have
been approved for listing on the Exchange, subject only to notice of issuance, or the Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">n. <U>No Termination Event</U>. There shall not have occurred any event that would permit the Agents to terminate this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;13(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Indemnification and Contribution</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company Indemnification</U>. The Company agrees to indemnify and hold harmless the Agents, their partners, members, directors,
officers, employees and agents and each person, if any, who controls the Agents within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any
untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make
the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the
omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate
amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission; provided that (subject to <U>Section</U><U></U><U>&nbsp;11(d)</U> below) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed or withheld; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) against any and all expense whatsoever, as incurred (including the reasonable and
documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and disbursements of counsel), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or
proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under
(i)&nbsp;or (ii) above, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided, however</I>, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the
extent arising out of any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with written information furnished to the Company by any Agent expressly for use in the Registration
Statement (or any amendment thereto), or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification by the Agents</U>. Each Agent, severally and not jointly, agrees to indemnify and hold harmless the Company and its
directors and officers, and each person, if any, who (i)&nbsp;controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act or (ii)&nbsp;is controlled by or is under common control with the
Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in <U>Section</U><U></U><U>&nbsp;11(a)</U>, as incurred, but only with respect to untrue statements or omissions, or alleged untrue
statements or omissions, made in the Registration Statement (or any amendments thereto) or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information
relating to the Agents and furnished to the Company in writing by such Agent expressly for use therein. The Company hereby acknowledges that the only information that the Agents have furnished to the Company expressly for use in the Registration
Statement, the Prospectus, any Prospectus Supplement or any Issuer Free Writing Prospectus (or any amendment or supplement thereto) are the statements set forth in the seventh paragraph under the caption &#8220;Plan of Distribution&#8221; in the
Prospectus (the &#8220;<U>Agents Information</U>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Procedure</U>. Any party that proposes to assert the right to be
indemnified under this <U>Section</U><U></U><U>&nbsp;11</U> will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this
<U>Section</U><U></U><U>&nbsp;11</U>, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from
(i)&nbsp;any liability that it might have to any indemnified party otherwise than under this <U>Section</U><U></U><U>&nbsp;11</U> and (ii)&nbsp;any liability that it may have to any indemnified party under the foregoing provisions of this
<U>Section</U><U></U><U>&nbsp;11</U> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it
notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the
commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the
indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees,
expenses and other charges of such counsel will be at the expense of such indemnified party unless (1)&nbsp;the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2)&nbsp;the indemnified party
has reasonably concluded (based on written advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3)&nbsp;a conflict or
potential conflict of interest exists (based on written advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such
action on behalf of the indemnified party) or (4)&nbsp;the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which
cases the reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is
understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable and documented <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such reasonable and
documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the indemnifying party receives a written
invoice relating to fees, disbursements and other charges in reasonable detail. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall,
without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this
<U>Section</U><U></U><U>&nbsp;11</U> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1)&nbsp;includes an unconditional release of each indemnified party from all liability arising out of such
litigation, investigation, proceeding or claim and (2)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Contribution</U>. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in
the foregoing paragraphs of this <U>Section</U><U></U><U>&nbsp;11</U> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or an Agent, the Company and such Agent will contribute to the total
losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after
deducting any contribution received by the Company from persons other than the Agents, such as persons who control the Company within the meaning of the Securities Act or the Exchange Act, officers of the Company who signed the Registration
Statement and directors of the Company, who also may be liable for contribution) to which the Company and the Agents may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand
and the Agents on the other hand. The relative benefits received by the Company on the one hand and the Agents on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before
deducting expenses) received by the Company bear to the total compensation received by the Agents (before deducting expenses) from the sale of Placement Shares on behalf </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is
appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and such Agent, on the other hand, with respect to the statements or omission that resulted in
such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or such Agent, the intent of the parties and their relative knowledge, access to
information and opportunity to correct or prevent such statement or omission. The Company and each Agent agree that it would not be just and equitable if contributions pursuant to this <U>Section</U><U></U><U>&nbsp;11(d)</U> were to be determined by
pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or
damage, or action in respect thereof, referred to above in this <U>Section</U><U></U><U>&nbsp;11(d)</U> shall be deemed to include, for the purpose of this <U>Section</U><U></U><U>&nbsp;11(d)</U>, any legal or other expenses reasonably incurred by
such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with <U>Section</U><U></U><U>&nbsp;11(c)</U> hereof. Notwithstanding the foregoing provisions of this
<U>Section</U><U></U><U>&nbsp;11(d)</U>, an Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of
Section&nbsp;11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this <U>Section</U><U></U><U>&nbsp;11(d)</U>, any person who controls a party to this
Agreement within the meaning of the Securities Act or the Exchange Act, and any officers, directors, partners, employees or agents of an Agent, will have the same rights to contribution as that party, and each officer who signed the Registration
Statement and director of the Company will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against
such party in respect of which a claim for contribution may be made under this <U>Section</U><U></U><U>&nbsp;11(d)</U>, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that
party or parties from whom contribution may be sought from any other obligation it or they may have under this <U>Section</U><U></U><U>&nbsp;11(d)</U> except to the extent that the failure to so notify such other party materially prejudiced the
substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of <U>Section</U><U></U><U>&nbsp;11(c)</U> hereof, no party will be liable for contribution with respect
to any action or claim settled without its written consent if such consent is required pursuant to <U>Section</U><U></U><U>&nbsp;11(c)</U> hereof. The Agents&#8217; respective obligations to contribute pursuant to this Section&nbsp;11(d) are several
in proportion to the respective number of Placement Shares they have sold hereunder, and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Representations and Agreements
to Survive Delivery</U>. The indemnity and contribution agreements contained in Section&nbsp;11 of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their
respective dates, regardless of (i)&nbsp;any investigation made by or on behalf of the Agents, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the
Placement Shares and payment therefor or (iii)&nbsp;any termination of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. An Agent may terminate this Agreement with respect to itself, by notice to the Company, as hereinafter specified at any time (1)&nbsp;if
there has been, since the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse Effect, or any development that would have a Material Adverse Effect that, in the sole judgment
of such Agent, is material and adverse and makes it impractical or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (2)&nbsp;if there has occurred any material adverse change in the financial
markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political,
financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of such Agent, impracticable or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares,
(3)&nbsp;if trading in the Common Stock has been suspended or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices for trading have been fixed on the Exchange,
(4)&nbsp;if any suspension of trading of any securities of the Company on any exchange or in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market shall have occurred and be continuing,
(5)&nbsp;if a major disruption of securities settlements or clearance services in the United States shall have occurred and be continuing, or (6)&nbsp;if a banking moratorium has been declared by either U.S. Federal or New York authorities. Any such
termination shall be without liability of any party to any other party except that the provisions of <U>Section</U>&nbsp;9 (Payment of Expenses), <U>Section</U><U></U><U>&nbsp;11</U> (Indemnification and Contribution),
<U>Section</U><U></U><U>&nbsp;12</U> (Representations and Agreements to Survive Delivery), <U>Section</U><U></U><U>&nbsp;18</U> (Governing Law and Time; Waiver of Jury Trial) and <U>Section</U><U></U><U>&nbsp;19</U> (Consent to Jurisdiction) hereof
shall remain in full force and effect notwithstanding such termination. If an Agent elects to terminate this Agreement as provided in this Section&nbsp;13(a), such Agent shall provide the required notice as specified in Section&nbsp;14 (Notices).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. The Company shall have the right, by giving one (1)&nbsp;day&#8217;s notice as hereinafter specified to terminate this Agreement in
its entirety or with respect to any one or multiple of the Agents, in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of
<U>Section</U><U></U><U>&nbsp;9</U> (Payment of Expenses), <U>Section</U><U></U><U>&nbsp;11</U> (Indemnification and Contribution), <U>Section</U><U></U><U>&nbsp;12</U> (Representations and Agreements to Survive Delivery),
<U>Section</U><U></U><U>&nbsp;18</U> (Governing Law and Time; Waiver of Jury Trial) and <U>Section</U><U></U><U>&nbsp;19</U> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. Nothing in this
Section&nbsp;13(b) shall limit the ability of the Company to suspend offers and sales of Placement Shares pursuant to the provisions of Section&nbsp;4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Each Agent shall have the right, by giving one (1)&nbsp;day&#8217;s notice as hereinafter specified to terminate this Agreement with
respect to itself in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of <U>Section</U><U></U><U>&nbsp;9</U> (Payment of
Expenses), <U>Section</U><U></U><U>&nbsp;11</U> (Indemnification and Contribution), <U>Section</U><U></U><U>&nbsp;12</U> (Representations and Agreements to Survive Delivery), <U>Section</U><U></U><U>&nbsp;18</U> (Governing Law and Time; Waiver of
Jury Trial) and <U>Section</U><U></U><U>&nbsp;19</U> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. Unless earlier terminated pursuant to this <U>Section</U><U></U><U>&nbsp;13</U>, this
Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through the Agents on the terms and subject to the conditions set forth herein except that the provisions of <U>Section</U><U></U><U>&nbsp;9</U>
(Payment of Expenses), <U>Section</U><U></U><U>&nbsp;11</U> (Indemnification and Contribution), <U>Section</U><U></U><U>&nbsp;12</U> (Representations and Agreements to Survive Delivery), <U>Section</U><U></U><U>&nbsp;18</U> (Governing Law and Time;
Waiver of Jury Trial) and <U>Section</U><U></U><U>&nbsp;19</U> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. This Agreement shall remain in full force and effect unless terminated pursuant to <U>Sections 13(a)</U>, <U>(b</U>), <U>(c</U>), or
<U>(d)</U>&nbsp;above or otherwise by mutual agreement of the parties; <I>provided, however</I>, that any such termination by mutual agreement shall in all cases be deemed to provide that <U>Section</U><U></U><U>&nbsp;9</U> (Payment of Expenses),
<U>Section</U><U></U><U>&nbsp;11</U> (Indemnification and Contribution), <U>Section</U><U></U><U>&nbsp;12</U> (Representations and Agreements to Survive Delivery), <U>Section</U><U></U><U>&nbsp;18</U> (Governing Law and Time; Waiver of Jury Trial)
and <U>Section</U><U></U><U>&nbsp;19</U> (Consent to Jurisdiction) shall remain in full force and effect. Upon termination of this Agreement, the Company shall not have any liability to an Agent for any discount, commission or other compensation
with respect to any Placement Shares not otherwise sold by an Agent under this Agreement. To the extent this Agreement is terminated by one Agent or by the Company with respect to one Agent pursuant to Sections 13(a), (b) or (c)&nbsp;above, this
Agreement shall terminate only with respect to such Agent and shall remain in full force and effect with respect to the Company and the other Agents, unless and until terminated pursuant to Sections 13(a), (b), (c) or (d)&nbsp;above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. Any termination of this Agreement shall be effective on the date specified in such notice of termination; <I>provided, however</I>, that
such termination shall not be effective until the close of business on the date of receipt of such notice by an Agent or the Company, as the case may be; <I>provided further</I>, that such Agent shall suspend any ongoing Placement as soon as
practicable following receipt of the notice of termination (and in any event by the close of business on the date of receipt). If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall
settle in accordance with the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Notices</U>. All notices or other communications required or permitted
to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified, and if sent to the Agents, shall be delivered to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Riley Securities, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">299 Park Avenue, 21<SUP STYLE="font-size:75%; vertical-align:top">st</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, NY 10171 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: &#8194;&#8194;General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone: &#8194;&#8201;(212) <FONT STYLE="white-space:nowrap">457-9947</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: &#8195;&#8194;&#8194;&#8201;&#8201;atmdesk@brileysecurities.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">BTIG, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">65 East 55<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: Equity Capital Markets </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: BTIGUSATMTrading@btig.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">with copies (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">BTIG, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">350 Bush Street, 9th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94104 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel and Chief Compliance Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: BTIGcompliance@btig.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">IBLegal@btig.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy
to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Duane Morris LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">22 Vanderbilt </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">335 Madison Avenue, 23<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, NY 10017 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: &#8194;&#8194;Dean M. Colucci </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone:&#8194;&#8201; (973) <FONT STYLE="white-space:nowrap">424-2020</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: &#8195;&#8194;&#8194;&#8201;&#8201;dmcolucci@duanemorris.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and if to the Company, shall be delivered to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Hyperfine, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">351 New Whitfield Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Guilford, Connecticut 06437 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: &#8194;&#8194;Brett Hale, Chief Administrative Officer and Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone: &#8194;&#8201;(866) <FONT STYLE="white-space:nowrap">796-6767</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">One Financial Center </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Boston, MA 02111 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: &#8194;&#8194;Michael L. Fantozzi </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">John T. Rudy </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">Anne L. Bruno
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Telephone: &#8201;&#8201;(617) <FONT STYLE="white-space:nowrap">542-6000</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Email: &#8194;&#8201;&#8194;&#8194;&#8194;mlfantozzi@mintz.com; jrudy@mintz.com; albruno@mintz.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each party to this Agreement may change such information for notices by sending to the parties to this Agreement written notice of new information for such
purpose. Each such notice or other communication shall be deemed given (i)&nbsp;when delivered personally, by email, or by verifiable facsimile transmission on or before 4:30 p.m., New York City time, on a Business Day or, if such day is not a
Business Day, on the next succeeding Business Day, (ii)&nbsp;on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii)&nbsp;on the Business Day actually received if deposited in the U.S. mail (certified or
registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#8220;<U>Business Day</U>&#8221; shall mean any day on which the Exchange and commercial banks in the City of New York are open for business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be
binding upon the Company and each Agent and their respective successors and the affiliates, controlling persons, officers and directors referred to in <U>Section</U><U></U><U>&nbsp;11</U> hereof. References to any of the parties contained in this
Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted
assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither the Company nor the Agents may assign its rights or obligations under this Agreement without the
prior written consent of the other party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Adjustments for Stock Splits</U>. The parties acknowledge and agree that all <FONT
STYLE="white-space:nowrap">share-related</FONT> numbers contained in this Agreement shall be adjusted to take into account any share consolidation, stock split, stock dividend, corporate domestication or similar event effected with respect to the
Placement Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Entire Agreement; Amendment; Severability</U>. This Agreement (including all schedules and exhibits attached
hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter
hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the Agents. In the event that any one or more of the provisions contained herein, or the application thereof in any
circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the
remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and
provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>GOVERNING LAW AND TIME;
WAIVER OF JURY TRIAL</U>. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. THE COMPANY
AND THE AGENTS EACH HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>CONSENT TO JURISDICTION</U>. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS
SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR
PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL
SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS
AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Use of Information</U>. The Agents may not use or disclose any information gained in connection with this Agreement and the
transactions contemplated by this Agreement, including due diligence, for any purpose except in connection with entering into this Agreement and providing services as Agents hereunder, except as expressly approved by the Company in its sole
discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile transmission or email of a .pdf attachment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Effect of Headings</U>. The section, Schedule and Exhibit headings herein are for convenience only and shall not affect the
construction hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Permitted Free Writing Prospectuses</U>. The Company represents, warrants and agrees that, unless it obtains
the prior consent of each Agent, which consent shall not be unreasonably withheld, conditioned or delayed, and each Agent represents, warrants and agrees that, unless it obtains the prior consent of the Company, which consent shall not be
unreasonably withheld, conditioned or delayed, it has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a &#8220;free writing
prospectus,&#8221; as defined in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by the Agents or by the Company, as the case may be, is hereinafter referred to as a &#8220;Permitted Free Writing
Prospectus.&#8221; The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, and has complied and will
comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the parties hereto agree that all
free writing prospectuses, if any, listed in <U>Exhibit 23</U> hereto are Permitted Free Writing Prospectuses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Absence of Fiduciary Relationship</U>. The Company acknowledges and agrees that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. Each Agent is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction
contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any
other party, on the one hand, and the Agents, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not any Agent has advised or is advising the Company on
other matters, and the Agents have no obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions
contemplated by this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. The Agents have not provided any legal, accounting, regulatory or tax advice with respect to the
transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. it is aware that the Agents and their affiliates are engaged in a broad range of transactions which may involve interests that differ from
those of the Company and such Agent have no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. it waives, to the fullest extent permitted by law, any claims it may have against the Agents for breach of fiduciary duty or alleged breach
of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that the Agents shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty
claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company, other than in respect of the Agents&#8217; obligations under this Agreement and to keep information provided
by the Company to the Agents and their counsel confidential to the extent not otherwise publicly-available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>Definitions</U>. As
used in this Agreement, the following terms have the respective meanings set forth below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Applicable Time</U>&#8221; means
(i)&nbsp;each Representation Date and (ii)&nbsp;the time of each sale of any Placement Shares pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Company&#8217;s knowledge</U>,&#8221; &#8220;<U>knowledge of the Company</U>&#8221; and similar expressions mean the actual
knowledge of an executive officer of the Company as of the date to which the expression relates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Issuer Free Writing
Prospectus</U>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, relating to the Placement Shares that (1)&nbsp;is required to be filed with the Commission by the Company, (2)&nbsp;is a &#8220;road show&#8221;
that is a &#8220;written communication&#8221; within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with the Commission, or (3)&nbsp;is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the
Placement Shares or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to
Rule 433(g) under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Rule 172</U>,&#8221; &#8220;<U>Rule 405</U>,&#8221; &#8220;<U>Rule 415</U>,&#8221;
&#8220;<U>Rule 424</U>,&#8221; &#8220;<U>Rule 424(b)</U>,&#8221; &#8220;<U>Rule 430B</U>,&#8221; and &#8220;<U>Rule 433</U>&#8221; refer to such rules under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All references in this Agreement to financial statements and schedules and other information that is &#8220;contained,&#8221;
&#8220;included&#8221; or &#8220;stated&#8221; in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is
incorporated by reference in the Registration Statement or the Prospectus, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All references in this Agreement to the
Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing Prospectus
(other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all references in this
Agreement to &#8220;supplements&#8221; to the Prospectus shall include, without limitation, any supplements, &#8220;wrappers&#8221; or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by
the Agents outside of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">26. <U>Waiver</U>.&nbsp;A waiver of any right, power or remedy under this Agreement must be in
writing signed by the party granting it. A waiver only affects the particular obligation or breach for which it is given. It is not an implied waiver of any other obligation or breach or an implied waiver of that obligation or breach on any other
occasion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of the page intentionally left blank] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the understanding between the Company and each of the Agents, please
so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and each of the Agents. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>HYPERFINE, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Brett Hale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Brett Hale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Chief Administration Officer, Chief Financial Officer, Treasurer and Corporate Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>ACCEPTED as of the date first-above written:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>B. RILEY SECURITIES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Joseph Nardini</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Joseph Nardini</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: SMD, Head of Investment Banking</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>BTIG, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Mark Seacrest</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Mark Seacrest</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Amended and Restated At Market Issuance Sales Agreement</I>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 1 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF PLACEMENT NOTICE </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">&#8201;&#8201;From:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hyperfine, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">&#8201;&#8201;To:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[B. Riley Securities, Inc.][BTIG, LLC]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">&#8201;&#8201;Attention:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[&#149;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">&#8201;&#8201;Subject:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At Market Issuance&#8212;Placement Notice</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">&#8201;&#8201;Date:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms and subject to the conditions contained in the Amended and Restated At Market Issuance Sales Agreement by and between
Hyperfine, Inc., a Delaware corporation (the &#8220;<U>Company</U>&#8221;), and B. Riley Securities, Inc. and BTIG, dated December&nbsp;29, 2025, the Company hereby requests that the [<I>identify Designated Agent</I>] sell up to [____] of the
Company&#8217;s Class&nbsp;A Common Stock, par value $0.0001 per share, at a minimum market price of $ per share, during the time period beginning [month, day, time] and ending [month, day, time]. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 2 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Compensation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall pay to the Designated Agent in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount equal to up to
3.0% of the gross proceeds from each sale of Placement Shares. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 3 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notice Parties </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>The Company </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maria Sainz </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brett Hale </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>B. Riley Securities </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Keith Pompliano </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scott Ammaturo </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy to <U>atmdesk@brileysecurities.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>BTIG
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carrie Taylor </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dean O&#8217;Connor </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with copies to <U>BTIGUSATMTrading@btig.com</U> and <U>BTIGcompliance@btig.com</U> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT 7(1) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of Representation Date Certificate </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>___________, 20___ </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Representation Date Certificate (this &#8220;<U>Certificate</U>&#8221;) is executed and delivered in connection with <U>Section</U><U></U><U>&nbsp;7(1)</U> of the Amended and Restated At Market Issuance Sales Agreement (the
&#8220;<U>Agreement</U>&#8221;), dated December&nbsp;29, 2025, and entered into by and between Hyperfine, Inc. (the &#8220;<U>Company</U>&#8221;) and B. Riley Securities, Inc. and BTIG (together, the &#8220;<U>Agents</U>&#8221;). All capitalized
terms used but not defined herein shall have the meanings given to such terms in the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned, a duly appointed and
authorized officer of the Company, hereby certifies, in the undersigned&#8217;s capacity as an officer of the Company and not in the undersigned&#8217;s individual capacity, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. As of the date of this Certificate, (i)&nbsp;the Registration Statement does not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the statements therein not misleading and (ii)&nbsp;neither the Registration Statement nor the Prospectus contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (iii)&nbsp;no event has occurred as a result of which it is
necessary to amend or supplement the Prospectus in order to make the statements therein not untrue or misleading for this paragraph 1 to be true. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Each of the representations and warranties of the Company contained in the Agreement were, when originally made, and are, as of the date of
this Certificate, true and correct in all material respects, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Except as waived by the Agents in writing, each of the covenants required to be performed by the Company in the Agreement on or prior to
the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement, has been duly, timely and fully performed in all material respects and each condition required to be complied with
by the Company on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement has been duly, timely and fully complied with in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Subsequent to the date of the most recent financial statements in the Prospectus, and except as described in the Prospectus, including
Incorporated Documents, there has been no Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. No stop order suspending the effectiveness of the Registration
Statement or of any part thereof has been issued, and no proceedings for that purpose have been instituted or are pending or threatened by any securities or other governmental authority (including, without limitation, the Commission). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. No order suspending the effectiveness of the Registration Statement or the qualification
or registration of the Placement Shares under the securities or Blue Sky laws of any </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">jurisdiction are in effect and no proceeding for such purpose is
pending before, or threatened, to the Company&#8217;s knowledge or in writing by, any securities or other governmental authority (including, without limitation, the Commission). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. and Duane Morris LLP are entitled to rely on this Certificate in connection with the
opinions such firms are rendering to the Agents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned has executed this Representation Date Certificate as of the date first
written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>HYPERFINE, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT 23 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Permitted Issuer Free Writing Prospectuses </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hypr-20251229.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 12/29/2025 9:16:18 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:hypr="http://hyperfine.io/20251229"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://hyperfine.io/20251229"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hypr-20251229_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hypr-20251229_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hypr-20251229_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 12/29/2025 9:16:18 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hypr-20251229_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 12/29/2025 9:16:18 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hypr-20251229.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g76508g1223171912109.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76508g1223171912109.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !K %4# 2(  A$! Q$!_\0
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M^$@C6=\@C;$H5BN?4L5_ 'UH \(\2:Y<>)?$FH:S=9\R[F,FW.=J_P *_0#
M_"LJBI;:WEN[J&V@0O-,XCC0=68G 'YT :<F@S1>$8=?D)6.>\:UB7'WMJ!F
M;\R!^=8]>Z?&?P_%X6^&WA#1H<?Z+(ZNP_B<J"[?BQ)KPN@"Q:_Q?A11:_Q?
MA10 V[_X_)_^NC?SJ&IKO_C\G_ZZ-_.H: /M2UT6#Q%\*[/1[G'EW>DQ19(^
MZ3&N&_ X/X5\9WUE/INH7-C=(4N+>5HI%/9E.#^HK[?\)_\ (FZ'_P!@^#_T
M6M?.?Q_\,?V1XUCUB&/%MJL>]B!P)4P&_,;3^)H X+P9X=?Q5XMT_2 2L4LF
MZ>3^Y$O+MGM\H/XXKTK5M>A^)^D>)]'MXU5M(;[=H:*H!^SQJ(WC'U4!L>I]
MJYO0O^*2^%VJ:^WR:CKS'3+ ]"L YF<>QX7V-<KX2\03>%O%6GZS%D_9I09$
M'\<9X=?Q4D4 8M>J? ;PO_;?CK^TYH]UKI*><<C@RGA!^'+?\!KE?B'X>A\.
M^+[F*SPVFW:K>6+KT:"3YEQ].1^%?2GP9\+_ /"-?#VT:5-MYJ'^ES9'(##Y
M!^"X_$F@#C_VE?\ D Z%_P!?4G_H(KYQKZ._:5_Y .A?]?4G_H(KYQH L6O\
M7X446O\ %^%% #;O_C\G_P"NC?SJ&IKO_C\G_P"NC?SJ&@#[G\)_\B;H?_8/
M@_\ 1:U@?%3P9)XV\&O86JI]OAF2:V9S@ YPP)]-I;\A6_X3_P"1-T/_ +!\
M'_HM:V* /C;XGZI;3^(XM$TULZ5H4 L+;'1F7_6/]2V>>^!7$UU/Q%\-MX5\
M=ZIIF"(!+YMN3WC?YE^N,X^H-<M0![+X&T6'XH>'-%TRY=/MGAV]59MQP9;!
MSNQ[D,NT>@-?3*@*H50  , #M7B/[.GAG[)H=_XCF3$EZ_V> G_GFA^8_BW'
M_ *]OH \._:5_P"0#H7_ %]2?^@BOG&OH[]I7_D Z%_U]2?^@BOG&@"Q:_Q?
MA11:_P 7X44 >QS?LX^(Y)Y)!K&E89B>LG<_[M,_X9N\2?\ 09TK\Y/_ (FO
MI>B@"CHME)IF@Z=82LKR6MK'"S+T)50"1[<5>HHH \O^+'PKG\?7&GWNG75M
M:WENK12M/NP\9Y7H#R#G_OJO./\ AF[Q)_T&=*_.3_XFOI>B@#-T#1X/#_A^
MPTBV'[JT@6(''WB!R?J3D_C6E110!YY\6/A_J'C_ $[3;;3[NUMVM9GD<W&[
M!! '& :\K_X9N\2?]!G2OSD_^)KZ7HH ^:X_V<O$D>?^)SI//_73_P")HKZ4
MHH **\6^#'CC5);>TT;Q+/++_:"O/I5[.Y8S;6*R1%C_ ! @D9[?A71?%7Q;
M?:9IKZ#X?8G6[JVDG>1#C[+;(I+R$]B<$#W]\4 >CT5S_@6XFN_ .@7-Q+)-
M-+80N\DC%F8E!DDGJ:PO@_?WFI?#^&XOKJ:YG-U.IDF<NV!(0!DT =[17BFD
M^-=9\/>.O$=UJ]Q)<>%6UA[%Y'<L;"3JC8[1G.#V_KZ!\1[R:U^&VN7EE<O%
M*EH7BFA<@CIR"* .KHKEK_P_)XJ\+:5"^M:KISK''*T]A<>7)(=F,,<'(YS]
M:\[3P=>M\4)/"Y\;>*OL:Z2+X2?;_P!YO,NS&<8QCVH ]MHKF])\(G2O#U]I
M!U_6KLW>[_2[FYWSP[E"_(V.,8R/<URNH_#FVTG3KC4+[X@^+H+6WC,DLC:D
M,*!_P&@#TZBO%_ _@C5_$>FSZOJ7BCQ3:V%S)NTV$ZBPF,/.'D.,9;@@ =/7
M-% ">!?"J>*_@3I=O%+]GU*VFFN+"Z'#0S+*Q4Y]#T/_ -85M6?A:_TKP%XJ
MUSQ%(L_B75-/G:[D&"(4$;;8EQP !Z=_H*M_ [_DDVE?[\W_ *-:NI\9?\B-
MX@_[!MQ_Z+:@"K\//^2<>&_^P;!_Z *Y_P""7_)-H/\ K[N/_1AKH/AY_P D
MX\-_]@V#_P! %8'P2_Y)M!_U]W'_ *,- $'@6PM=4OOB%87T"3VMQK4L<L;C
M(92HKE/$][>>"O"&O^!M9F:6QELW?0[^0_ZQ 1F!C_?7M[?@*[3X:_\ (>\=
M_P#8>D_]!%6OB[IUGJ'PRUEKNW25K:$SPENL<@Z,#^)_.@#J=$_Y &G?]>L7
M_H(KBX_^3A)_^Q;7_P!'UVFB?\@#3O\ KUB_]!%<7'_R<'/_ -BVO_H^@#T.
MO,+@M\5/%)LTR?!VCS_Z0X^[J-RO\ ]8U[^OX@CI?B7<36OPV\036\KQ2K9N
M Z'!&>#@_0U\B67B_P 2:;9QVECKNHVUM'G9%#<LBKDYX /K0!]R*H10J@!0
:,  <"BOB/_A/?%__ $,^K_\ @8_^-% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g76508g1223171912214.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g76508g1223171912214.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  W "L# 2(  A$! Q$!_\0
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MWAVWDS;Z<OF3 '@S./Z+C_OHUN?!GXB6^E_#W6K/4I,G1(VNH%)Y>)C]P?\
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0""..-;.?"@?\ _6BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001833769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 29,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Hyperfine, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1569027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">351 New Whitfield Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Guilford<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">06437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">796-6767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class&#160;A common stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HYPR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d76508d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d76508d8k.htm">d76508d8k.htm</File>
    <File>hypr-20251229.xsd</File>
    <File>hypr-20251229_lab.xml</File>
    <File>hypr-20251229_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d76508d8k.htm": {
   "nsprefix": "hypr",
   "nsuri": "http://hyperfine.io/20251229",
   "dts": {
    "inline": {
     "local": [
      "d76508d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "hypr-20251229.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "hypr-20251229_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hypr-20251229_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-12-29_to_2025-12-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d76508d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-12-29_to_2025-12-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d76508d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://hyperfine.io//20251229/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-335370-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-335370-xbrl.zip
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M<W/D%M]>$\RF*CD2H@M\60[J,RY$7N&Y#?BJ?1?H K#:@1"XG?!)(\#<@TO
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M^4OD&<A%)^+8.7&$'UXT[1(V\L7K/]Z['3RM^O).MP+A_*ENSML"/,)W=QZ
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M+'8L_>)S> W@D(/JU8PZLV)FAG3D[>#2W"$"EFL "V%V M7+]3B4GC+])BT
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M@U8?2IZSJ?3GW7=WLV=(/-AK\ORWLEA@$PCXYF]K6$@P8]HS"O5%=_V+9X.
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MV[DK!@EX'<0FY(R'^:6LE]_K@63D [E )\RMW<9D?0IK]'?SA<J2--LS+F_
M97DJMOM0M6E0"SUU!J Q2 G1=ZB67,&-M&5"!T"K]*A(E/ON>'./$/UK)B$)
MX=9!_RX\R:X+5\(K@8D4C&9RKI'RX&'L! X-VC%10LXJC\';./##2+:@.3C+
M!YI!J\(1E0516S>$[:2VB:G\>G3TAD]\XY:;4I>]8W1ER7L<B/Z4R+TX'H*
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MR=^^Y/_K7]JKX.62B7]!B-!(G,H1V-]S+M=(EF>7:LUXJ;CQRFZ-F5,\G ,
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MF/Z-;S(';C-1<V'F55EX?/,JAU/:*D/1!M DJ16/HM"ZP&G=70M-W#D(M(K
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M? )J1G+**<6:6*R4'G!>D4?G/^JF,>#,3$83B<JVYV9'?'$T+3RP:*O%18"
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MD72V-];+96'J!BT@I!B-8QTW;=N<T[=R)4ZG0\PF;X8UI68<',6RTY$B#BY
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M$?BFRF.CRB)13UWZK$*K9+);%X ^KRH!HT1FH;Y;(:Z(=XF"715BY2),I.K
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M]<\^3LIIJWO4[O=E,DY/H9/P+1JR#Y/#$X3SUFT?'/:I$9Q@?)JF&V<,GNK
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MT"!-Y4#=.!3P*;MX 'L+@]:U)B0/7.!A1I^4,@IYC+0.1:5(52X*9+T,(K<
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MN^L0RP*4SZ_[W&87T:58/BP_OV[BV Y490Y5&\U B]>M63YBE)J,>;^@=)!
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M07&<HV@2OKL*T4'S^?W&YJ(6\97G<3(,$_6;K8U-W,ZN-.39JZ%W1+V>]\)
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MX!.^$ADI;)KH/U7,U+1-C0K?9%%XX[+,*$ '!"U$,2;D_9D4E$7U:^$TJ>U
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M]5>8K=_A;F=XU]NM=M;0YR]02P,$%     @ -H*=6S"QEH.,!@  J$8  !4
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MLC.:]&T6B:S9*PV&UTQR#,]$>*I?SS3E\5%RQV#:K6!%$ 6J%D%J9M,2H&N
M*4*&;PNM6SFNW3_%8N$SFW&S2!;Q)W]1FVA[;J=+A1(C6![COE"PZ=&N$QXJ
M@"E!M$IHHV_+(J%V\Q0@7X@ Y1)E<JOD)M:#<X(KO4C9G&#8D.L]4IUB7L\F
MUDYQ'X(:\K0SL540DHJ0E013DVA(_@=?EIEYNCF*(3KG$?NT6DR9;#8QQ;Q.
MQ\-B .W'W<%_K$5+N5&'5)X(:.I^+?36:IH"U(F_O@CU8HG?\O3F^%.H+17I
M%.%]UK!&L#O<E<*TI.M2L%V+EOM6K5B&X E^*$;B. RU 97]=\D%&S8;!ZM
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MZ^:(^6>>W<26KU!+ 0(4 Q0    ( #:"G5MUVF](QQ,  +YX   -
M      "  0    !D-S8U,#AD.&LN:'1M4$L! A0#%     @ -H*=6YQL.Y'U
MI0  2C4# !               ( !\A,  &0W-C4P.&1E>#$P,2YH=&U02P$"
M% ,4    "  V@IU;*C!DKGX+  !W*0  #P              @ $5N@  9#<V
M-3 X9&5X-3$N:'1M4$L! A0#%     @ -H*=6QD?/L0Z P  /PL  !$
M         ( !P,4  &AY<'(M,C R-3$R,CDN>'-D4$L! A0#%     @ -H*=
M6S"QEH.,!@  J$8  !4              ( !*<D  &AY<'(M,C R-3$R,CE?
M;&%B+GAM;%!+ 0(4 Q0    ( #:"G5MN )4PS@0  #,L   5
M  "  >C/  !H>7!R+3(P,C4Q,C(Y7W!R92YX;6Q02P4&      8 !@![ 0
&Z=0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d76508d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hypr-20251229.xsd" xlink:type="simple"/>
    <context id="duration_2025-12-29_to_2025-12-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001833769</identifier>
        </entity>
        <period>
            <startDate>2025-12-29</startDate>
            <endDate>2025-12-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-285">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-12-29_to_2025-12-29"
      id="Hidden_dei_EntityCentralIndexKey">0001833769</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-296">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-297">2025-12-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-298">Hyperfine, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-299">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-300">001-39949</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-301">98-1569027</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-302">351 New Whitfield Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-303">Guilford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-304">CT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-305">06437</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-306">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-307">796-6767</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-308">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-309">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-310">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-311">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-312">Class&#160;A common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-313">HYPR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-314">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-315">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2025-12-29_to_2025-12-29" id="ixv-316">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
